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CHAPTER-I 
 
INTRODUCTION 
Medicinal and aromatic plants have been used since ancient times in the 
traditional practices for health care. it is well known that plants are an important 
source for a variety of bioactive compounds for a variety of purposes including 
pharmacy ,medicine and industry, According to WHO report nearly 70-80% of the 
world population relies on traditional medicine largely which are produces plant 
based for primary health care needs. the annual international market of herbal product 
is estimated to be US$20 million. with increasing popular demand for medicinal 
plants both in india and internationally. 
 
Human being had depended only on natural sources to a larger extent 
particularly on plants of his vicinity for getting rid of these ailments. 
 
 Besides for his other needs Several potent medicinal plants have seen the light 
of the day due to his continous usage of the effective drugs, Some of these plants have 
attracted the herbalist who have put these plants in to use for centuries together and 
included the more potent one in the materia medica of their region. 
 
Scientific study of folk medicine is very essential because the  efficacy of a 
drug depends upon various factors such as genuinity, preparation administration and 
dosage of drugs. 
 
Pharmacognosy is the study of crude drugs obtained from plants, animals and 
mineral kingdom and their constituents. Even though science of Pharmacognosy is 
practiced since a very early period. 
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The term Pharmacognosy was first used by C.A. SEYDLER, a German 
Scientist, in 1865 in his book Analecta Pharmacognostica. It is derived from two 
Latin words Pharmakon, “a drug” and gignosco, “to acquire knowledge of”. It means 
knowledge or science of drugs.
1,2,3,4,5
 
 
NEUROPATHY
 
A classical term for any disorders affecting any segment of the nervous 
system. 
 
NEUROPATHIC PAIN
 
Neuropathy is a collection of disorders that occurs when nerves of the 
peripheral nervous system (the part of the nervous system outside of the brain and 
spinal cord) are damaged. The condition is generally referred to as peripheral 
neuropathy, and it is most commonly due to damage of nerve axons. Neuropathy 
usually causes pain and numbness in the hands and feet. It can result from traumatic 
injuries, infections, metabolic disorders, and exposure to toxins.
79, 80
 
 
Neuropathy can affect nerves that control muscle movement (motor nerves) 
and those that detect sensations such as coldness or pain (sensory nerves). In some 
cases - autonomic neuropathy - it can affect internal organs, such as the heart, blood 
vessels, bladder, or intestines. Pain from peripheral neuropathy is often described as a 
tingling or burning sensation. There is no specific length of time that the pain exists, 
but symptoms often improve with time - especially if the neuropathy has an 
underlying condition that can be cured. The condition is often associated with poor 
nutrition, a number of diseases, and pressure or trauma, but many cases have no 
known reason and other wise called as idiopathic neuropathy. 
 3 
 
NEUROPATHY CLASSIFICATION 
Peripheral neuropathy can be broadly classified into the following categories: 
 Mononeuropathy - involvement of a single nerve. Examples include carpal 
tunnel syndrome, ulnar nerve palsy, radial nerve palsy, and peroneal nerve 
palsy. 
 Multiple mononeuropathy - two or more nerves individually affected. 
 Polyneuropathy - generalized involvement of peripheral nerves. Examples 
include diabetic neuropathy and Guillain-Barre syndrome. 
Neurophathies may also be categorized based on a functional classification 
(motor, sensory, autonomic, or mixed) or the type of onset (acute - hours or days, 
subacute - weeks or months, or chronic - months or years).The most common form of 
neuropathy is (symmetrical) peripheral polyneuropathy, which mainly affects the feet 
and legs on both sides of the body. 
CAUSES OF NEUROPATHY 
About 30% of neuropathy cases are considered idiopathic, which means they 
are of unknown cause. Another 30% of neuropathies are due to diabetes. In fact, about 
50% of people with diabetes develop some type of neuropathy. The remaining cases 
of neuropathy, called acquired neuropathies, have several possible causes, including 
 Trauma or pressure on nerves, often from a cast or crutch or repetitive motion 
such as typing on a keyboard. 
 Nutritional problems and vitamin deficiencies, often from a lack of B 
vitamins. 
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 Alcoholism, often through poor dietary habits and vitamin deficiencies. 
 Autoimmune diseases, such as lupus, rheumatoid arthritis, and Guillain-Barre 
syndrome. 
 Tumors, which often press up against nerves. 
 Other diseases and infections, such as kidney disease, liver disease, Lymph 
disease, HIV/AIDS, or an underactive thyroid (hypothyroidism). 
 Inherited disorders (hereditary neuropathies), such as Charcot-Marie-Tooth 
disease and amyloid polyneuropathy. 
 Poison exposure, from toxins such as heavy metals, and certain medications 
and cancer treatments. 
WHO GETS NEUROPATHY? 
Risk factors for peripheral neuropathy include several conditions and 
behaviors. People with diabetes who poorly control their blood sugar levels are very 
likely to suffer from some neuropathy. Autoimmune diseases such as lupus and 
rheumatoid arthritis also increase one's chance of developing a neuropathy. People 
who have received organ transplants, AIDS patients, and others who have had some 
type of immune system suppression have a higher risk of neuropathy. In addition, 
those who abuse alcohol or have vitamin deficiencies (especially B vitamins) are at an 
increased risk. Neuropathy is also more likely to occur in people with kidney, liver or 
thyroid disorders. 
 
 SYMPTOMS OF NEUROPATHY 
Neuropathy symptoms depend on several factors, chiefly where the affected nerves 
are located and which type of nerves are affected (motor, sensory, autonomic). 
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Several types of neuropathy affect all three types of nerves. Some neuropathies 
suddenly arise while others come on gradually over the course of years.  
 
Motor nerve damage usually leads to symptoms that affect muscles such as 
muscle weakness, cramps, and spasms. It is not uncommon for this type of neuropathy 
to lead to a loss of balance and coordination. Patients may find it difficult to walk or 
Peripheral neuropathic pain has been frequently observed in patients with 
cancer,AIDS,longstanding diabetes,lumbar disc syndrome,herpes infection,traumatic 
spinal cord injury,multiple sclerosis and stroke. Moreover,post thoracotomy,post-
herniorrhaphy,post-mastectomy,and post-sternotomy have also been associated with 
neuropathic pain. 
a) Facial weakness and ptosis 
b) Sensory Loss 
c) Signs of autonomic disturbances Eg: Postural Hypotension 
a. Pain and numbness in hand and feet 
d) Absent or reduced reflexes 
e) Ataxia and skeletal weakness 
 
DISEASES OF PERIPHERAL NERVES
 
Neuropathy is a group of diseases of nerves not associated with inflammation. They 
are classified as. 
I. Parenchymal (polyneuropathy)   -several neurons are affected. 
II. Interstitial (mononeuropathy)     -A single neurone is usually affected 
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I. Parenchymal (polyneuropathy) 
Damage to a number of neurons and their myelin sheaths (ie. The long neurons are 
usually affected first. Those supplying the feet and legs. 
 
II. Interstitial neuropathy (mononeuropathy) 
Single nerve involved and the most common causes due to pressure. 
a).compression: compression of radial nerve against humerus. 
b).Entrapment:Carpal Tunel Syndrome-compression of median nerve as it                                         
passes through the carpal tunel in the flexor retinaculam at the wrist. 
 
ANIMAL MODELS OF NEUROPATHIC PAIN
 
1. Chemical Induced Model 
       a) Acrylamide induced neuropathy. 
2. Disease Induced model 
 a) Diabetes induced model. 
 b) Cancer pain model. 
3. Peripheral nerve injury model 
 a) Chronic constriction injury model 
 b) Complete sciatic nerve transition model 
  c) Partial sciatic nerve ligation model   
 d) Spinal nerve ligation model 
 e) Tibial and sural nerve transition model 
 f) Common peroneal nerve ligation model 
4. Drug induced model 
 a) Vincristine induced model 
 b) Anti HIV drug induced model 
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5. Micellaneous model 
 a) Chronic ethanol consumption/withdrawal induced neuropathy 
 b) Pyridoxine defficiency induced neuropathy 
 
 NEUROPATHY CURES BY HERBS
 
Neuropathy is a term that refers to problems associated with the peripheral 
nervous system and it may cause muscle weakness, spasms, cramps, and pain. These 
symptoms can be easily triggered by outside stimuli and they may occur over again 
unless treated. There are some herbal remedies that can cure or treat these conditions 
without the side effects of allopathic medicine. 
 Hypericum perforatum  
 Polygonum multiflorum. 
 Levisticum officinale  
 Filipendula ulmaria. 
 
HEPATOCELLULAR CARCINOMA (HCC) 
This is the most common form of liver cancer in adults. It begins in the hepatocytes, 
the main type of liver cell. About 3 out of 4 cancers that start in the liver are this type. 
HCC may have different growth patterns.
6
 
 Some start as a single tumor that grows larger. Only late in the disease does it 
spread to other parts of the liver. 
 Others seem to start in many spots throughout the liver, not as a single tumor. 
This is most often seen in people with ongoing liver damage (cirrhosis) and is 
the most common pattern seen in the United States. 
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Pathologist can figure out the subtypes of hepatocellular cancer by looking at the 
cancer under a microscope. Most of these subtypes do not affect treatment or the 
patient's outlook. But one rare type, called fibrolamellar, has a much better outlook 
(prognosis) than other forms of liver cancer. 
  An estimated 26,190 new cases of liver cancer (including intrahepatic bile 
duct cancers) are expected to occur in the US during 2011. More than 80% of these 
cases are hepatocellular carcinoma (HCC), originating from hepatocytes, the 
predominant type of cell in the liver. The incidence of liver cancer has been 
increasing by 3.4% per year in men and by 3.0% per year in women since 1992. In 
contrast to most common cancer sites, incidence rates are highest among Asian 
Americans/Pacific Islanders and Hispanics. 
 
Liver cancer (hepatocellular carcinoma) is a cancer arising from the liver. It is 
also known as primary liver cancer or hepatoma. The liver is made up of different cell 
types (for example, bile ducts, blood vessels, and fat-storing cells). However, liver 
cells (hepatocytes) make up 80% of the liver tissue. Thus, the majority of primary 
liver cancers (over 90%-95%) arises from liver cells and is called hepatocellular 
cancer or carcinoma. 
 
 SCOPE OF THE LIVER CANCER PROBLEM 
Liver cancer is the third most common cancer in the world. A deadly cancer, 
liver cancer will kill almost all patients who have it within a year. In 2000, it was 
estimated that there were about 564,000 new cases of liver cancer worldwide, and a 
similar number of patients died as a result of this disease. About three-quarters of the 
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cases of liver cancer are found in Southeast Asia (China, Hong Kong, Taiwan, Korea, 
and Japan). 
The frequency of liver cancer in Southeast Asia and sub-Saharan Africa is 
greater than 100 cases per 100,000 populations.  
Cancer a dreadful disease occurring due to anomalybin mitotic cell cycle is the 
second cause of death in developed countries, approximately one in five die of cancer, 
According to WHO out of an estimated total of 50 million deaths annually in the 
world more than five million are attributed to cancer and the number of deaths from 
throughout the world is increasing approximately 500,000 new case of cancer are 
observed. Hepatocellular carcinoma (HCC) is the fifth most common cancer 
worldwide and its incidence in the United States and other countries has been steadily 
increasing over the past 25 years. 
Causes, incidence, and risk factors   
Hepatocellular carcinoma accounts for most liver cancers. This type of 
cancer occurs more often in men than women. It is usually seen in people age fifty 
or older. However the age varies in different parts of the world. The disease is 
more common in parts of Africa and Asia than in North or South America and 
Europe. Hepatocellularcarcinomais not the same as metastatic liver cancer, which 
starts in another organ (such as the breast or colon) and spreads to the liver. In 
most cases, the cause of liver cancer is usually scarring of the liver (cirrhosis). 
Cirrhosis may be caused by: 
 Alcohol abuse (the most common cause in the United States) 
 Autoimmune diseases of the liver 
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 Hepatitis B or C virus infection 
 Inflammation of the liver  
 Iron overload in the body (hemochromatosis) 
Patients with hepatitis B or C are at risk for liver cancer, even if they have not 
developed cirrhosis. 
Symptoms 
1. Abdominal pain or tenderness, especially in the upper-right part 
2. Easy bruising or bleeding 
3. Enlarged abdomen 
4. Yellow skin or eyes (jaundice) 
SIGNS AND TESTS 
Physical examination may show an enlarged, tender liver. 
Tests include: 
 Abdominal CT scan 
 Abdominal ultrasound 
 Liver biopsy 
 Liver enzymes (liver function tests) 
 Liver MRI 
 Serum alpha fetoprotein 
Some high-risk patients may get regular blood tests and ultrasounds to see whether 
tumors are developing. 
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ANTIOXIDANT APPROACH OF HERBAL MEDICINE 
Herbal medicine is prepared from a variety of plant materials-leaves, stems, 
roots, bark and so on. Living plants may be considered as a biosynthetic laboratory 
not only for primary metabolites, and also secondary metabolites such as glycosides, 
alkaloids, flavonoids, terpenoids and tannins etc that are responsible for treating mild 
and chronic ailments.
8, 9,10. 
 
 Diseases are due to the shift in the balance of pro-oxidant and antioxidant. 
Pro-oxidant conditions dominate either due to the increased generation of the free 
radicals caused by excessive oxidative stress of the current life (or) If not effectively 
scanned by cellular constituents and depletion of the dietary antioxidant may leads to 
various disease conditions, such as rheumatoid arthritis, hemorrhagic shock, CVS 
disorders, neurodegenerative disease, AIDS and Gastrointestinal ulcerogenesis have 
been reported. 
 
 Antioxidants are capable of protecting against the damage induced by free radicals 
also has a role in reducing the effects of diabetes. 
 Plant materials have been used in the treatment of malignant diseases. It has been 
estimated that over 60% of anticancer drugs in current use are derived from plants. 
 Nutrional factors and oxidative damage which plays critical role in the 
pathophysiology of numerous neurodegenerative diseases such as Alzheimer’s 
and Parkinson’s disease. 
 Thus the evaluation of antioxidant potential of centrally acting drugs are  
 
Becoming more relevant and essential. 
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CHAPTER-II 
REVIEW OF LITERATURE  
 
The literature survey of Ipomoea sepiaria Koen ex Roxb Reveals that the following works 
have been already done on the plant. 
ETHANOMEDICAL INFORMATION: 
 The plant is extensively used as fodder for cattle.  
 Ipomoea sepiaria plant juice have been used in folk medicine for the treatment of 
deobstruent oedema, diabetic mellitus and nervous disorder. 
 The plant is used for sterility in women, urinary retention, constipation and 
gynecological disorders. 
 Ipomoea stans and ipomoea batatas have been reported for anticancer activity. 
 
Ipomoea sepiaria: 
   1. Syed shayfur Rahman studied the Investigation of Sapindus mukorossi extracts for    
repellency, Insectidal Activity and plant growth regulatory effect.
54
 
  2. Ray.B,et.al studied the antimicrobial activity potentiality of Ipomoea sepiaria   
(convolvulaceae).
51
 
 3. Vijayan Mini N, et.al studied the antimicrobial activity of ten common 
herbs,commonly known as Dashapushpam from kerala,India.
52
 
  4. Abdul Latif L, et.al reported the efficacy of some organic modification for the control 
of ufra disease of Rice.
53
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OTHER SPECIES: 
 Shukla G and Verma BK (1990) have described the taxonomy of Ipomoea 
batatas, Ipomoea carica, Ipomoea hederifolia, Ipomoea aquatia, Ipomoea pes-
tigridis, Ipomoea turbinata, Ipomoea carnea, Ipomoea obscura, Ipomoea sepiaria 
and Iopomea sinensis .
11
 
 Singh V and Gupta  PC (1995) have isolated  a water  soluble seed gum 
polysaccharide containing D-galactose and D-mannose as sugars from Ipomoea 
pes-tigridis and its structure elucidation has been described.
12
 
 Parveen F and Bhandari MM (1982) have discussed the polynogical account of 
7 genera and 23 species of Convolvulaceae found in Indian desert and pollen 
morphology in relation to taxonomy of the family.
15
 
  Karatela YY and Gill LS (1985) have described the epidermal morphology and 
stomatal ontogency of ten plant (Convolvulaceae) species. The leaves of the 
plants shows amphistomatic, paracytic stomata type with eumesogenous ontogeny 
in all the Convolvulaceous species except in two Ipomea species.
16
 
 Siddiqi TO et al.,  (1990)  have identified the botanical character of Kaladana  
(Ipomoea hederarea).
17
 
 Goto T et al., (1981) have reported the structure of an alkali hydrolysis product of 
heavenly blue anthocyanin (HBA) which was isolated from blue flowers of 
morning glory (Ipomoea spp),and it was determined to be trans-o–[6-o-(-trans-3-
o-β-D—caffeyl)-β-D- glucopyronosyl] caffeic acid by spectral studies.19 
14 
 
 Takagi S et al., (1981) have isolated the isoquercitrin monoacetate, isoquercitrin 
hyperin and quercetin sodium salt from Ipomoea biloba by column 
chromatography and were identified by thin layer chromatography.
20
 
   Dubey P et al., (1982) have described the isolation of a new flavanoid from 
ethyl acetate extract of Ipomoea fistulosa and its structure was elucidated by 
spectral studies.
21
 
    Schneider JA et al., (1984) have isolated nine new sesquiterpenes from the root 
of Ipomoea batatas and their structures were also determined.
22
 
 Harrison DA and Kulshreshtha DK (1986) have examined the four new fatty 
acid glycosides from Ipomoea dichroa. They were identified as dichrosides A, B, 
C and D besides  friedelin, stearic acid, β-sitosterol and its glucosides.23 
 Wilkinson RE et al., (1987) have isolated the seed alkaloids from Ipomoea 
hederifolia, Ipomoea coccinea and, Ipomoea wrightii and these alkaloids were 
quantified by spectrophotometry as ergonovine maleate equivalents.
24
 
    Ono M et al., (1991) have isolated the ether soluble resin glycosides, operculins 
from the roots of Ipomoea operculata. These were characterized on the basis of 
chemical and spectral analysis.
25
 
    Ysrael MC and Waterman PG (1994) have evaluated the isolation of 
antifungal and cytotoxic principles from Ipomoea muricata.
26
                    
    Yahara S et al., (2002) have isolated the phenolic compounds from the 
methanolic extract of dried leaves of Ipomoea batatas and these compounds were 
identified by spectral studies.
27
                            
15 
 
 Kappor A et al., (1981) have demonstrated the petal extracts of Ipomoea carnea, 
Ipomoea palmate exhibit antifungal activity against Alternarria brassicae, 
Alternaria brassicicola and Fusarium oxysporium due to presence of some 
flavonoids.
30
 
  Khare AK et al., (1982) have evaluated the anti-inflammatory activity of 
Ipomoea turpethinum. The aqueous extract of root showed more potent activity 
(38.3) against acute, subacute and chronic inflammation in carageenan induced 
paw edema model compared to alcoholic (32%) and ethereal extract (26%).
31
 
  Mujumdar AM et al., (1983) have demonstrated that the ethanol extracts of 
Ipomoea leari seeds produced depression at low doses and stimulation at higher 
doses, ultimately which lead to convulsions in mice and at higher doses analgesic 
activity was noted. The antibacterial activity was also studied.
32
     
 Da silvo filho AA et al., (1986) have described the isolation of four new 
antimicrobial glycosides from Ipomoea bahensis. They showed significant activity 
against sarcoma 180 in mice.
33
         
 Pongprayoon U (1991) has studied the effect of extract of Ipomoea pes-caprae in 
the treatment of dermatitis caused by poisonous jelly fish toxins. It also exhibited 
significant antispasmodic activity in isolated guinea pig ileum and anti-
inflammatory in carageenan induced in rat paw edema.
34
 
 Reza MS et al., (1994) have studied the antibacterial activity of the chloroform 
extract of different parts of Ipomoea fistulosa against all the strains of Shigella 
and the gram positive bacteria namely Bacillus megaterium and Bacillus 
polymyxa. The extract exhibited significant activity.
35
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  Reynolds WF et al., (1995) have isolated and characterized the cytotoxic and 
antibacterial tetrasaccharide glycoside from Ipomoea stans. These compounds 
have pronounced cytotoxicity towards three human tumor cell lines as well as 
specific antibiotic activity against two bacterial strains.
36
      
    Navarro-Ruiz A et al., (1996) have demonstrated the anti-convulsant effect of 
aqueous, hydroalcoholic and chloroform extracts from roots of Ipomoea stans. 
Maximal electroshock seizure inducing test (MES) and subcutaneously injected 
metrazole (METSC) were the premental epilepsy model used and maximum 
activity was seen with aqueous extract.
37
 
 Matsui T et al., (2002) have performed anti-hyperglycemic effect of diacylated 
anthocyanin derived from Ipomoea batatas. They suggested that anthocyanin had 
alpha glucosidase inhibitory activity after a single oral administration in 8week 
old male rats.
38
 
 Barnes CC et al., (2003) have reported that the organic soluble extract from the 
leaves of Ipomoea leptophylla showed activity against M. tuberculosis (Invitro 
method).
39
    
 Dhembare AJ and Sangle S (2003) evaluated the effect of various plant extracts 
(Piper nigrum, Ipomoea fistulosa) for their antimicrobial activity against human 
pathogenic bacterial strains.
40
 
 Haueza IM et al., (2003) have reported the immunomodulatory activity of 
Ipomoea carnea on peritoneal cells of rat model. The experimental model 
suggested that low doses of Ipomoea carnea induced enhanced phagocytosis 
activity and hydrogen peroxide production by macrophages.
41
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 Yoshimoto M et al., (2004) have estimated the phenolic composition and radical 
scavenging activity of sweet potato Ipomoea batatas treated with Koji 
[Aspergillus awamori and cellulase (cellulosin T2)].
42
  
 Prasad KN et al., (2006)  have studied callus induction from Ipomoea aquatica 
Forsk leaf and its antioxidant activity. The antioxidant activity was analysed by 
DPPH, TBARS and metal chelating methods. Hyper antioxidant activity was 
observed in one month old callus produced by NAA in combination with 
Kinetin.
43
 
 Ferreira AA et al., (2006) have evaluated the anti-nociceptive effect from 
Ipomoea cairica.  The ethanolic extract (100,300,1000 and 3000mg/kg; per oral) 
of Ipomoea cairica induced dose dependent reduction of response in the formalin 
test inflammatory phase in mice model. The same dose range did not modify 
neurogenic pain in formalin test, tail flick reflex latency, and carageenan induced 
paw edema and rota-rod test motor performed.
44
 
  Datta Choudry M et al., (2007) have studied the chemical characterization and 
antifungal, CNS depressant activity of Ipomoea aquatica. The methanolic extract 
of Ipomoea aquatica showed the antifungal activity against Candida albicans 
(1.6cm) and for CNS depressant activity in mice was as potent as standard.
45
 
   Sokeng SD et al., (2007)  have demonstrated the  inhibitory effect of Ipomoea 
aquatica extracts on glucose absorption using a perfused rat intestinal preparation 
model. The aqueous/dichloromethane/methanol extracts showed the significant 
inhibitory effect on glucose absorption in test animals. The most pronounced 
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effect was observed with the aqueous extract. Quabain was used as a reference 
inhibitor.
46
 
  Hamsa TB and Kuttan G (2007) have reported the antioxidant activity of 
methanolic extract of  Ipomoea obscura in vitro and in vivo models. In vitro 
model, the extract was found to have potential antioxidant activity as it could 
inhibit lipid peroxidation, and scavenge hydroxyl, superoxide and nitric oxide 
radicals generated. In vivo model, the extract (10mg/kg]) was found to inhibit the 
PMA induced superoxide generation in mice peritoneal macrophages.
47
       
  Vimala Y et al., (2007) have demonstrated the antimicrobial activity of Ipomoea 
kentrochulos on microorganisms and microbial isolates on spoiled vegetable by 
disc diffusion method. The minimal inhibitory effect of crude residual extract was 
determined by tube dilution against different microbes which range more than 
800µg/ml.
48
 
  Rivera IL et al., (2008) have studied the anti-mycobacterial and, cytotoxicity 
and effects on the central nervous system of Ipomoea tyrianthina.
49
 
 Chimkode R et al., (2009) have evaluated the wound healing activity of tuberous 
root extracts of Ipomoea batatas in vivo model. The petroleum ether extract 
showed more potent wound healing activity (dead space granulation) models 
compared to other extracts.
50
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CHAPTER-III 
AIM AND SCOPE 
 
Ipomoea sepiaria Koen.ex Roxb. (convulvulaceae) is a glabrous or 
occasionally pubescent, hirsute,slender twiner with a slightly thickend or tuberous 
perennial root and short stem producing annual or seasonal,It is available throughout 
india in the plains especially near the coast and up to an elevation of about 500 feet in 
the hills,It also grows near water margin. This plant is used in traditional medicine as 
a popular remedy to treat various ailments. 
The ethanomedical information revealed that almost all parts of this plant are 
employed in various indigenous system of medicine against several diseases. 
 
 The plant is extensively eaten as pot herb also used as fodder for cattle.  
 Ipomoea sepiaria plant juice has been used in folk medicine for the 
treatment of deobstruent, diuretic, diabetic and nervous disorders.  
 This plant is also used for sterility in women, urinary retention, constipation 
and gynecological disorders. 
 Ipomoea batatas and ipomea stans have been reported for anti cancer 
activity. 
According to the information available from the literature survey, this plant has 
not been reported for painful neuropathy though ethanomedical information indicates 
that it has been used for the treatment of nervous disorders. Pharmacognostical  and  
Phytochemical studies also not been reported for the leaves of this plant. 
 
So, the present work has been designed to carry out the following works on 
the leaves and stems of Ipomoea sepiaria . 
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1. It is planned to carry out the detailed Pharmacognostical studies on the leaves 
and stem of this plant. 
2. Preliminary phytochemical studies were carried out for the crude drug as well 
as extracts, in order to confirm the presence of primary and secondary 
metabolites like proteins, carbohydrates, terpenoids, flavonoids and tannins.  
3. To estimate the total phenolic, and flavonoid content in the extracts of this 
plant. 
4. Phytochemical evaluation including isolation, identification and 
characterization of secondary metabolites. 
5. It is planned to evaluate the extract of this plant for the following 
pharmacological studies. 
 
a. Determination of antioxidant potential of extracts by, 
i  Hydrogen peroxide scavenging activity. 
b. Evaluation of antioxidant potential of extracts and isolated compounds by, 
       ii  DPPH (2,2,diphenyl-2-picryl hydrazyl) assay. 
       c. Pharmacological Evaluation of Ipomoea sepiaria on Acrylamide induced 
neuropathic pain in rats. 
      d. Pharmacological Evaluation of Ipomoea sepiaria against invitro anti cancer 
activity for  HepG2 cancer cell lines. 
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CHAPTER-IV 
PHARMACOGNOSTICAL STUDIES 
 
 Ipomoea sepiaria .Koen. ex Roxb. is a slender twinning perennial plant belonging to 
the family convolvulaceae. 
 
SECTION-A 
 
SYSTEMATIC POSITION 
 
Kingdom  :  Plantae 
Subkingdom  : Tracheobionta 
Division              :  Magnoliophyta 
Super division : spermatophyta 
Class                 :  Magnoliopsida 
Subclass  : Asteridae 
Order          :  Solanales 
Family         :  convolvulaceae 
Genus         :  Ipomea 
Species               :  sepiaria 
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VERNACULAR NAMES 
English              :  Ipomoea sepiaria 
Tamil               :  Talikkirai, manjigai, 
Telugu               :  Mettatuti, purititige 
Hindi & Bengali   :  Bankalmi 
Malayalam       :  Tirutali 
Oriya              :  Bilona, Mushakani 
Marathi   : Amtivel 
Gujarathi   : Hanumanvels 
 
 
GEOGRAPHICAL DISTRIBUTION
 
Herbaceous slender, perennial twinner found almost throughout india in 
hedges,near streams and tanks. 
 
HABIT AND HABITAT OF PLANT 
Ipomoea sepiaria  is a glabrous or occasionally pubescent or hirsute, slender 
producing annually or seasonally a number of terete villous, greyish purple branches 
bearing simple cordate or ovate-cordate,variable medium size leaves blotched with 
brownish or purplish patches towards the centre. 
 
DESCRIPTION OF THE PLANT: 
The plant is a slender vine. It is found in the plains and on thickness of dry 
soil. The leaves are triangular-cordiform, glabros, base cordate, apex acute, petiole up 
to 2cm long flowers are umbellate cymes. Calyx lobes are unequal corolla cream 
colour with purple throat. Stamens are fine and unequal, Ovary conical  in shape 
stigma capitate, fruit are capsule and the seeds are white velvety.
55
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FOLIAGE 
Leaf arrangement  :  simple alternate 
Leaf type             :  petiolate 
Leaflet margin     :  entire 
Leaflet shape              :  ovate-cordate 
Leaflet venation          : less dense  and reticulate 
Leaf color                   :  dark green 
Size                         :  1.5 inch in long 
 
FLOWER 
Flower color  :  Pale purple, pink or white 
Flower characteristics :  Pedicelled, sepals five ovate or broadly elliptic, shortly 
apiculate, glaborous with membraneous margin. 
 
FRUIT 
Fruit shape  :  Ovoid capsule 
Fruit length  :  One fourth to one third inch in diameter 
Fruit covering  : Minutely tawny and velvety 
Fruit color  :  Grey 
SEED 
Light grey seeds usually 4 or 6 glaborous velvety or woolly 0.15 inch. 
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SECTION-B 
MICROSCOPICAL STUDY OF THE LEAVES
 
 
MATERIALS AND METHODS 
 Leaves and stem of Ipomoea sepiaria was collected from road side of 
Madurai. Care was taken to select healthy plants and normal organs. Samples of leaf 
and stem were cut and removed from this plant and fixed in FAA (formalin-
5ml+acetic acid-5ml+70%ethyl alcohol-90ml). After 24 hours of fixing, the 
specimens were dehydrated with graded series of tertiary-butyl alcohol as per the 
standard procedure  
 
Infiltration of the specimens were carried out by gradual addition of paraffin 
wax (melting point 58-60 c) until TBA solution attained super saturation. The 
specimens were cast into paraffin blocks.
56, 57, 58, 59, 60 , 61
 
 
SECTIONING 
The paraffin embedded specimen was sectioned with the help of rotary 
microtome. The thickness of the sections was 10-12µm, dewaxing of the sections was 
by customary procedure.. The sections were stained with toludine blue as per the 
method published by O’BRIEN et al. (1964). Since toludine blue is a polychromatic 
stain. The staining results were remarkably good; and some cytochemical reactions 
were also obtained. The dye rendered pink colour to the cellulose walls, blue to the 
lignified cells, dark green to suberin, violet to the mucilage, blue to the protein bodies 
etc. wherever necessary sections were also stained with saffranin and fast-green and 
iodine ( for starch) For studying the stomatal morphology, venation pattern and 
trichome distribution, paradermal sections (sections taken parallel to the surface of 
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leaf) as well as clearing of leaf with 5% sodium hydroxide or epidermal peeling by 
partial maceration employing  Jeffrey’s  maceration fluid (Sass,1940) were prepared. 
Glycerin mounted temporary preparations were made for macerated/ cleared material. 
Powdered materials of different parts were cleared with sodium hydroxide and 
mounted in glycerin after staining. Different cell component were studied and 
measured. 
 
PHOTOMICROGRAPHS 
Photographs of different magnifications were taken with Nikon lab photo 2 
microscopic units. For normal observation bright field was used. For the study of 
crystals, starch grains and lignified cells, polarized light was employed. Since these 
structures have birefringent property, under polarized light they appear bright against 
dark background. Magnification of the figures was indicated by the scalebars. 
 
Anatomical features: 
Leaf: 
The leaf consists of fairly prominent midrib and thick smooth lamina. The 
midrib consists of a broad short adaxial conical hump and wide convex abaxial part 
(fig 5.1). The midrib is 580µm thick and the adaxial cone is 250µm wide. The conical 
part includes a small mass of collenchymas and the remaining portion of the midrib 
consists of thin walled compact parenchymatous ground tissue. The palisade tissue 
extends up to the lateral part of the collenchyma mass. The vascular strand in single 
and fan-shaped in sectional view. It is 150µm thick and 250µm wide. The vascular 
strand consists of parallel rows of thin walled angular xylem elements and small 
groups of phloem elements both on the lower and upper ends of the vascular bundle 
(fig.5.1). 
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Lateral view: 
The lateral vein is slightly thicker than the lamina; it is 450µm thick. It 
consists of a single circular vascular strand surrounded by parenchymatous ground 
tissue. The vascular bundle comprises cluster of small angular xylem elements and a 
thin arc of phloem elements placed on the lower end. The vascular bundle is 150µm 
wide. 
 
LAMINA (fig.5.3): 
The lamina is 350µm thick. It is dorsiventral with distinct adaxial zone of 
palisade tissue and abaxial spongy parenchyma. The adaxial epidermis consists of 
fairly thick rectangular thin walled epidermal cells; the abaxial epidermis is 
comparatively thin, the cells being narrowly cylindrical. Both adaxial and abaxial 
epidermal layers are stomataferous. The palisade layer is single layered and the cells 
are short, wide and cylindrical. The spongy parenchyma cells are four or five layered 
cells being lobed and loosely arranged. 
 
EPIDERMAL CELLS AND STOMATAL MORPHOLOGY: 
The epidermal tissue was studied from the paradermal sections.The epidermal 
cells are angular and thick walled. The stomata are exclusively paracytic type.Each 
stoma has two or occasionally three subsidiary cells lying parallel to the guard cells. 
The stomata are elliptical in shape measuring 20x30µm in size. 
  
VENATION OF THE LAMINA (fig.7.1,2): 
The venation pattern is less dense reticulate; the shape and size of the vein-
islets. The veins are thin and undulate. The vein terminations are long, slender, curved 
and simple. Most of the terminations bud in a cluster of terminal-tracheids (fig.7.2). 
The tracheids are rectangular and square shaped with spiral thickenings. 
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PETIOLE (fig.8) 
The petiole is circular in sectional view with adaxial wide V-shaped groove. It 
is 1.2mm thick and 1.1mm wide. The epidermal layers of the petiole consists of fairly 
wide, thin walled rectangular or squarish cells with thin cuticle. Two or three outer 
layers of ground tissue are collenchymatous, the remaining portions being 
parenchymatous. The vascular system consists of a shallow arc of larger main bundle 
and two smaller circular wing bundles. The main bundle includes several short 
parallel rows of xylem elements and small groups of phloem units distributed both 
along the adaxial and abaxial sides of the xylem. 
 
POWDER MICROSCOPIC OBSERVATIONS: 
EPIDERMAL GLANDULAR TRICHOMES:(fig.9.1,2,3) 
Glandular trichomes are common on both adaxial and abaxial sides of the 
lamina. The adaxial epidermal cells are polygonal with thick straight anti clinal walls. 
The gland is a circular plate comprising about 8 triangular cells bounded by a thin 
cuticular membrane. The gland is 70µm in diameter (fig.9.1) 
The glandular trichomes on the abaxial side are similar to those on the adaxial 
side,except that the glands are smaller and thin walled (fig.9.3). The gland is 50µm in 
diameter. 
 
EPIDERMAL TISSUE (fig.10.1,2. 11.1,2): 
Fragments of epidermal peelings are frequently seen in the powder. They are 
seen in surface view. The abaxial epidermis tissue differ from the adaxial epidermis in 
shape and size of the cells as well as in the frequency of the stomata (compare fig.10.1 
and 11.1). The abaxial epidermal cells are larger in size their anticlinal walls are thin 
and wavy; the cells are amoeboid in outline. The stomata are paracytic with more or 
less equal subsidiary cells (fig.10.2).  The adaxial epidermal cells are smaller in size. 
Their anticlinal walls are thick and straight (fig 11.1). The stomata are paracytic type 
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and the subsidiary cells are mostly unequal in size (fig.11.2). The surface of the cells 
appears finely dotted cuticular markings. 
 
MICROSCOPIC FEATURES OF THE STEM: 
              The stem is circular with even surface, frequently seen on certain places (fig-
12.1,2). The stem is 1.2mm in thick. The epidermis is radially oblong , thin walled 
and wide. The cells are 20mm thick. Linear to the epidermis is seen the initial stage of 
periderm formation, which includes 2 or 3 layers of phloem. 
 
THE CORTEX: 
             The cortical cells are crushed in to dark layers of rectangular cells. The 
cortical zone is formed by a wide distinct zone of outer secondary phloem (fig-12,3). 
The outer phloem elements are wide, polygonal and are random in arrangement. It 
includes sieve elements and phloem parenchyma cells. 
 
SECONDARY XYLEM: 
              The xylem cylinder is somewhat elliptical in outline. Two opposite ends are 
thicker with inner primary xylem and outer secondary xylem. The other opposite ends 
are thin and possess primary xylem and lacks the secondary xylem (fig.12,2). The 
primary xylem consists of two several compact rows of cells, with two or three xylem 
elements in each row. Secondary xylem is at the initial stage if development. It 
includes solitary wide, circular vessels and thick walled fibers. 
 
                   The vessels are 130µm wide (fig.12.3) along the inner zone of the primary 
xylem occurs the inner phloem (also called medullary phloem or interxylary phloem). 
The inner phloem consists of isolated masses of phloem elements and parenchyma 
cells (fig.12.4). 
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           Calcium oxalate druses are common in the pith cells. The druses solitary and 
occurs in unmodified parenchyma cells, they are solitary and 20µm thick (fig.12.5). 
 
SECTION- D 
QUANTITATIVE MICROSCOPY
 
DETERMINATION OF LEAF CONSTANT: 
The vein islet number, vein termination number, stomatal number and 
stomatal index were determined on fresh leaves using standard procedure. 
 
A. Vein islet number and vein termination number: 
The term vein islet is used to denote the minute area of photo synthetic tissue 
encircled by the ultimate division of the conducting strands. The number of vein islets 
per square mm area is called vein- islet number. 
 
Vein termination number may be defined as the number of vein terminations 
present in one square mm area of the photosynthetic tissue. 
 
Determination of vein islet number and vein termination number: 
Pieces of leaves were cut from various regions of the leaves between midrib 
and the margin, cleared in chloral hydrate and mounted on a slide. Camera Lucida and 
drawing board were arranged.  With the help of a stage micrometer, camera Lucida 
and microscope, 1mm square was drawn on the paper.  Then the stage micrometer 
was replaced by the preparation and the veins were traced in that square.  Then the 
vein islets and vein terminations were counted in the square.  Ten such readings were 
taken and the average was calculated and the results were presented in TABLE-I. 
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TABLE -I 
VEIN ISLET NUMBER AND VEIN TERMINATION NUMBER OF THE 
LEAVES OF Ipomoea sepiaria 
OBSERVATION 
NUMBER 
VEIN ISLET 
NUMBER 
VEIN TERMINATION 
NUMBER 
 1 7 8 
2 8 6 
3 8 7 
4 9 9 
5 7 9 
6 7 6 
7 10 8 
8 8 9 
9 7 7 
10 7 7 
RANGE MINIMUM AVERAGE MAXIMUM 
Vein islet 7 8 10 
Vein termination 6 8 9 
 
A. Stomatal Number: 
The average number of stomata per square mm area of epidermis of the leaf is 
called stomatal number. 
 
Determination of Stomatal Number: 
Pieces of upper and lower epidermal peelings were mounted on a slide With 
the help of camera Lucida and stage micrometer 1 mm square was drawn on a paper.  
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The stage micrometer was replaced by the preparation.  Then the preparation was 
observed under high power and the stomata marked in that unit area.  Number of 
stomata present in those unit areas was calculated.  Ten such readings were taken and 
the average of stomatal number was calculated and presented in the TABLE-II. 
TABLE- II 
    STOMATAL NUMBER OF THE LEAVES OF Ipomea sepiaria 
OBSERVATION NUMBER LOWER EPIDERMIS 
1 29 
2 32 
3 27 
4 24 
5 30 
6 34 
7 28 
8 31 
9 27 
10 23 
RANGE MINIMUM AVERAGE MAXIMUM 
Lower epidermis 23 29 34 
 
A. Stomatal Index: 
Definition: 
It is the percentage which the numbers of stomata form to the total number of 
epidermal cells, each stoma being counted as one cell. 
Stomatal index          S.I =  ×100 
Where, S=number of stomata per unit area 
E= number of epidermal cells in the same unit area 
 
Determination of Stomatal Index: 
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The procedure adopted in the determination of stomatal number was followed 
and then the preparation was observed under high power.  The epidermal cells and the 
stomata were counted.  From these values the stomatal index was calculated using the 
above formula and the results were given in TABLE-III. 
TABLE - III 
STOMATAL INDEX OF THE LEAVES OF Ipomoea sepiaria 
 
OBSERVATION 
NUMBER 
LOWER EPIDERMIS 
1 11.11 
2 8.57 
3 8.57 
4 13.51 
5 17.95 
6 8.57 
7 13.51 
8 11.11 
9 5.88 
10 15.79 
RANGE MINIMUM AVERAGE MAXIMUM 
LOWER 
EPIDERMIS 
5.88 11.46 17.95 
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SECTION-E 
PHYSICAL PARAMETERS
 
The Physical parameters such as Total ash, Acid insoluble ash, Water soluble 
ash, Extractive values and Loss on drying were determined separately for air dried 
powdered leaves of this plant as per the official method. 
 
A.ASH VALUES: 
The ash values were determined by using air dried powdered leaves as per the official 
method. 
 
i. Total ash: 
2 grams of the crude leaf powder was accurately weighed in a tarred nickel 
crucible. The ground drug was scattered in a fine even layer on the bottom of the 
crucible and incinerated by gradually increasing the heat not exceeding 450˚c [dull 
red heat] until free from carbon. Then it was cooled and weighed for constant weight. 
The percentage of ash with reference to the air dried drug was calculated . 
 
ii. Acid insoluble ash: 
The ash obtained from the total ash was boiled for 5 minutes with 25ml of 2M 
hydrochloric acid. The insoluble matter was collected in a tarred sintered glass 
crucible. The residue was washed with hot water, ignited to constant weight, cooled in 
a desiccator and weighed. The percentage of acid insoluble ash with reference to the 
air – dried drug was calculated. 
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iii. Water soluble ash: 
For water soluble ash, ash obtained from the total ash was boiled with 25ml of 
distilled water. The insoluble matter was collected in a Gooch crucible, washed with 
hot water ignited to a constant weight. Cooled in a desiccator and weighed. The 
weight of the insoluble matter was subtracted from the weight of the ash. The 
differences gave the weight of the water soluble ash. It was calculated with reference 
to the air-dried powder. The results were represented in TABLE-IV. 
 
TABLE- IV   
       ASH VALUES 
OBSERVATION 
NUMBER 
 
TOTAL ASH 
     %W/W 
%W/ 
ACID 
INSOLUBLE 
ASH %W/W 
WATER 
SOLUBLE 
ASH %W/W 
1 16.31 6.82 - 
2 15.18 6.55 - 
3 15.63 5.97 - 
4 14.92 6.45 - 
5 16.88 5.65 - 
6 16.09 - 10.06 
7 15.34 - 9.83 
8 15.47 - 9.66 
9 15.24 - 10.14 
10 15.87 - 10.02 
MINIMUM 
 
14.92 5.65 9.83 
MAXIMUM 16.88 
 
6.82 
 
10.14 
 
AVERAGE 15.69 
 
6.55 
 
9.89 
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B. Determination of Extractive values 
i. Alcohol (Ethanol) soluble extractive: 
5 gm of the air –dried drug, coarsely powdered, was macerated in 100ml of 
ethanol in a closed flask for 24 hours, shaking frequently during 6 hrs and allowed to 
stand for 18 hrs, filtered rapidly, taking precautions against loss of solvent. 25ml of 
the filtrate was evaporated to dryness in a tarred flat bottomed shallow dish and dried 
at 105˚ c, to constant weight. The percentage of alcohol soluble extractive with 
references to the air - dried drug was calculated and presented in TABLE-V. 
 
ii. Determination of Water-Soluble Extractive: 
5 gm of the air dried drug coarsely powdered, was macerated in 100 ml of 
chloroform water in a closed flask for 24 hours, shaking frequently during 6 hours, 
and allowed to stand for 18 hours. Filtered rapidly, taking precautions against loss of 
solvent. 25 ml of the filtrate was evaporated to dryness in a tarred-flat-bottomed 
shallow dish and dried at 105˚ C to constant weight. The percentage of water – 
soluble extractive with reference to the air-dried drug was calculated and presented in   
TABLE –V. 
 
iii. Determination of Petroleum Ether soluble Extractive: 
5 gm of the air –dried drug, coarsely powdered, was macerated in 100ml of 
ethanol in a closed flask for 24 hours, shaking frequently during 6 hrs and allowed 
stand for 18 hrs. Thereafter it was filtered rapidly, taking precautions against loss of 
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petroleum ether. 25ml of the filtrate was evaporated to dryness in a tarred flat 
bottomed shallow dish and dried at 105˚ c, to constant weight. The percentage of 
petroleum ether soluble extractive with references to the air - dried drug was 
calculated and presented in TABLE-V. 
iv. Determination of Chloroform, Methanol, Ethyl acetate and Acetone soluble 
extractives: 
The procedure followed for the determination of alcohol soluble extractive 
value was adopted for the determination of benzene soluble extractive, Chloroform 
soluble extractive, methanol soluble extractive, ethyl acetate soluble extractive and 
acetone soluble extractive. Instead of alcohol, respective solvents were used for the 
determination of their extractive values.The percentage of chloroform, methanol, 
ethyl acetate and acetone soluble extractives with reference to air dried drug was 
calculated and presented in TABLE-V. 
 
TABLE-V. 
TOTAL EXTRACTIVE VALUES: 
S.NO SOLVENT EXTRACTIVE VALUE % 
1 Petroleum ether 4.95 
2 Chloroform 7.68 
3 Ethyl acetate 8.12 
4 Acetone 10.80 
5 Methanol 16.61 
6 Ethanol 7.12 
7 70% Ethanol 19.36 
8 Aqueous 10.76 
 
 
C. Loss on drying: 
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For the determination of loss on drying, the method described by Wallis was 
followed. 2 grams of the powdered crude drug was accurately weighted in a tarred 
dish and dried in an oven at 100˚ C. It was cooled in a desicator and again weighed. 
The loss on drying was calculated with reference to the amount of the dried powder 
taken and presented in TABLE –VI. 
TABLE -VI 
     LOSS ON DRYING 
OBSERVATION 
NUMBER 
LOSS ON 
DRYING % W/W 
1 11.37 
2 10.63 
3 10.03 
4 9.92 
5                                   10.71 
RANGE MINIMUM AVERAGE MAXIMUM 
Leaves &Stem 
powder 
9.92 10.53 11.37 
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CHAPTER –V 
                                  PHYTOCHEMICAL STUDIES 
 
The leaves and stem of Ipomoea sepiaria were collected in Madurai Dist, 
Tamilnadu and authenticated by Taxonomist.The shade dried leaves were powdered 
and then subjected to the following preliminary phytochemical tests.
66-70.
 
SECTION-A 
ORGANOLEPTIC EVALUATION 
 
1. Nature -  Coarse powder 
2. Colour -  Green in colour 
3. Odour  -  Characteristic odour 
4. Taste  -  Mild astringent 
  
Powdered plant material and extracts were subjected to the following chemical 
tests and the results were presented in the table No VII. 
 
SECTION-B 
B. QUALITATIVE CHEMICAL EXAMINATION OF THE POWDER OF 
Ipomoea sepiaria  
1. TEST FOR STEROLS 
      The powdered leaf was first extracted with petroleum ether and evaporated to 
a residue. Then the residue was dissolved in chloroform and tested for sterols. 
a. Salkowski’s Test 
 A few drops of concentrated sulphuric acid was added to the above solution, 
shaken well and set aside. The lower chloroform layer of the solution turned red in 
color indicating the presence of sterols. 
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.b.  Liebermann – Burchard’s Test 
 To the chloroform solution a few drops of acetic anhydride and 1 ml of 
concentrated Sulphuric acid were added through the sides of the test tube and set aside 
for a while. At the junction of two layers a brown ring was formed. The upper layer 
turned green indicating the presence of sterols.  
 
2. Test for Terpenoids 
A little of the powdered leaf was extracted with chloroform and filtered. The 
filtrate was warmed gently with tin and thionylchloride. The colour of the solution 
turned to pink indicates the presence of terpenoids. 
 
3. TEST FOR CARBOHYDRATES 
a. Molisch’s Test: 
 The aqueous extract of the powdered leaf when treated with alcoholic solution 
of α-naphthol in the presence of sulphuric acid gave purple color indicating the 
presence of carbohydrates. 
b. Fehling’s Test: 
 The aqueous extract of the powdered leaf was treated with Fehling’s solution I 
and II and heated on a boiling water bath for half an hour. Red precipitate was 
obtained indicating the presence of free reducing sugars. 
 
4. TEST FOR FLAVONOIDS 
a. Magnesium turning- con HCl test: 
        A little of the powdered drug was heated with alcohol and filtered. To the test 
solution magnesium turnings and few drops of concentrated hydrochloric acid were 
added and boiled for five minutes. Red or magenta color was obtained indicating the 
presence of flavonoids. 
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b. Alkali Test 
       To the small quantity of test solution 10% aqueous sodium hydroxide Solution 
was added.  Yellow orange color was produced indicating the presence of flavonoids.  
C. Acid Test 
To the small quantity of test solution, few drops of concentrated Sulphuric 
acid were added. Yellow to crimson color was obtained indicates the presence of 
flavonoids. 
 
7. TEST FOR PROTEINS 
a. Millon’s Test  
A small quantity of aciduous – alcoholic extract of the powdered drug  was 
heated with Millon’s reagent. White precipitate turned red on heating Indicate the 
presence of proteins.  
b. Biuret Test  
           To another portion of aciduous – alcoholic extract of the powdered drug one ml 
of 10% sodium hydroxide solution was added, followed by this one drop of dilute 
copper sulphate solution was added. Violet color was obtained indicating the presence 
of proteins. 
 
8. TEST FOR ALKALOIDS 
a. About 2gm of the powdered material was mixed with 1gm of calcium 
hydroxide and 5ml of water into a smooth paste and set aside for 5 minutes. It was 
then evaporated to dryness in a porcelain dish on a water bath. To this 200ml of 
chloroform was added, mixed well and refluxed for half an hour on a water bath. 
Then it was filtered and the chloroform was evaporated. To this 5ml of dilute 
hydrochloric acid was added followed by 2ml of each of the following reagents. 
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a) Mayer’s Reagent                        -           No   cream precipitate 
b) Dragendorff’s Reagent               -           No orange brown precipitate 
c) Hager’s Reagent                         -           No Yellow precipitate  
d) Wagner’s Reagent                      -            No Reddish brown precipitate 
b. Test for Purine group (Murexide test) 
                The residue obtained after the evaporation of chloroform as described in (a) 
was treated with 1ml of hydrochloric acid in a porcelain dish and 0.1gm of Potassium 
chlorate was added and evaporated to dryness on a  water bath. Then the residue was 
exposed to the vapour of dilute ammonia solution. No purple Color was obtained 
indicating the absence of purine group of alkaloids. 
 
9. Test for Glycosides 
a. Borntrager’s Test 
            The powdered leaf was boiled with dilute sulphuric acid, filtered and to the 
filtrate, benzene was added and shaken well. The organic layer was separated to 
which ammonia solution was added slowly. 
 No color reaction was observed in ammoniacal layer showing the absence of 
Anthraquinone glycosides. 
b. Modified Borntrager’s Test 
              About   0.1g of the powdered drug was boiled for 2minutes with dilute 
Hydrochloric acid and few drops of ferric chloride solution, filtered while hot and 
cooled. The filtrate was then extracted with benzene and the benzene layer was 
separated. Equal volume of dilute ammonia solution was added to the Benzene 
extract. 
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No pink color was observed in ammoniacal layer showing the absence of 
anthraquinone glycosides. 
 
10. TEST FOR CARDIAC GLYCOSIDES (FOR DEOXYSUGAR) 
a. Keller Kiliani Test 
          About 1g of the powdered leaf was boiled with 10ml of 70% alcohol for 2 
minutes, cooled and filtered. To the filtrate 10ml of water and 5 drops of Solution of 
lead acetate were added and filtered, evaporated to dryness. The Residue was 
dissolved in 3 ml of glacial acetic acid. To this 2 drops of ferric chloride solution was 
added. Then 3 ml of concentrated sulphuric acid was added to the sides of the test 
tube carefully and observed. 
No reddish brown layer was observed indicating the absence of deoxysugars 
of cardiac glycoside 
b. Test for Cyanogenetic Glycosides 
               Small quantity of the powder was placed in a stoppered conical flask with 
just sufficient water, to cover it. A sodium picrate paper strip was inserted through the 
stopper so that it was suspended in the flask and it was set aside for 2 hours in a warm 
place. No brick red color was produced on the    paper indicating the absence of 
Cyanogenetic glycosides. 
 
11. TEST FOR SAPONINS  
              About 0.5g of the powdered drug was boiled gently for 2 minutes with 20ml 
of water and filtered while hot and allowed to cool. 5 ml of the filtrate was then 
diluted with water and shaken vigorously. Frothing was produced indicating the 
presence of saponins. 
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12. TEST FOR TANNINS  
           A small quantity of the powdered drug was extracted with water. To the 
aqueous extract few drops of ferric chloride solution was added. 
Bluish black color was produced indicating the presence of tannins. 
 
13. TEST FOR THE PRESENCE OF VOLATILE OIL 
Weighed quantity (250 gm) of fresh leaves was subjected to hydrodistillation 
using volatile oil estimation apparatus (BP 1980).  
No oil was collected indicating its absence in fresh leaves. 
 
14.  TEST FOR MUCILAGE 
Few ml of aqueous extract prepared from the powdered crude drug was treated 
with ruthenium red. No red colour reaction indicating the absence of Mucilage. 
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TABLE –VII 
PRELIMINARY PHYTOCHEMICAL SCREENING FOR THE POWDER OF 
Ipomoea sepiaria 
S.NO                                TEST RESULTS 
1. TEST FOR STEROLS  
 a. Salkowski’s test + 
 b. Libermann- burchard’s test + 
2. TEST FOR CARBOHYDRATES  
 a. Molisch’s test + 
 b. Fehling’s test + 
 c. Benedict’s test + 
3. TEST FOR PROTEINS  
 a. Millon’s test + 
 b. Biuret test + 
4. TEST FOR ALKALOIDS  
 a. Mayer’s reagent - 
 b. Dragendroff’s reagent - 
 c. Hager’s reagent - 
 d. Wagner’s reagent - 
 e. Test for Purine group (Murexide test ) - 
5. TEST FOR GLYCOSIDES  
 a. Anthraquinone glycosides  
     i) Borntrager’s test - 
     ii) Modified Borntrager’s test - 
 b. Cardiac glycosides  
     i) Keller Killiani test  - 
 c. Cyanogenetic glycosides - 
6. TEST FOR SAPONINS  
 Foam Test + 
7. TEST FOR TANNINS  
 Fecl3 test  + 
8. TEST FOR FLAVONOIDS  
 a. Shinoda test + 
 b. Alkali test + 
 c. Acid test + 
9. TEST FOR TERPENOIDS + 
10. TEST FOR VOLATILE OILS - 
11. TEST FOR MUCILAGE  - 
 
       (+) indicates positive reaction                 (-) indicates negative reaction        
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TABLE- VIII 
PRELIMINARY PHYTOCHEMICAL SCREENING FOR THE VARIOUS 
EXTRACTS OF LEAF POWDER OF Ipomoea sepiaria 
        Tests  Pet.ether 
Extract 
Chloroform 
Extract 
Ethyl 
acetate 
extract 
Acetone 
Extract 
Methanol 
Extract 
Ethanol  
Extract 
Aqueous 
extract 
I. Test for Sterols        
a. Salkowski’s test + + + + + + - 
b. Libermann- 
burchard’s test 
+ + + + + + - 
II. Test for 
Carbohydrates 
       
a. Molisch’s test - - - - + + + 
b. Fehling’s test - - - - + + + 
c. Benedict’s test - - - - + + + 
III.Test for Proteins        
a. Millon’s test - - - - + + + 
b. Biuret test - - - - + + + 
IV.Test for 
Alkaloids 
       
a.Mayer’s reagent - - - - - - - 
b. Dragendroff’s 
reagent 
- - - - - - - 
c. Hager’s reagent - - - - - - - 
d. Wagner’s reagent - - - - - - - 
e. Test for Purine 
group (Murexide test 
) 
- - - - - - - 
V.Test for 
Glycosides 
       
a. Anthraquinone 
glycosides 
- - - - - - - 
i) Borntrager’s test - - - - - - - 
ii) Modified 
Borntrager’s test 
- - - - - - - 
b. Cardiac glycosides        
i) Keller Killiani test  - - - - - - - 
c. Cyanogenetic 
glycosides 
- - - - - - - 
VI.Test for Saponins - - - - + + + 
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VII.Test for 
Tannins 
       
Fecl3 test  - - - + + + + 
VIII.Test for 
Flavonoids 
       
a. Shinoda test - - - + + + + 
b. Alkali test - - - + + + + 
c. Acid test - - - + + + + 
IX.Test for 
Terpenoids 
+ + + + + + - 
X.Test for Volatile 
Oils 
- - - - - - - 
XI.Test for 
Mucilage  
- - - - - - - 
 
    (+) Indicates positive reaction                 (-) Indicates negative reaction        
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SECTION-C 
ESTIMATION OF TOTAL PHENOLIC COMPOUNDS
  
Principle 
  The total phenolic content of the Ipomoea sepiaria extract was determined by 
Folin – Ciocalteu Reagent method. This regeant consists of a mixture of 
phosphotungstate and phosphomolybdate which is reduced, during oxidation of the 
phenolic substances, into a mixture of blue molybdenum and tungsten oxides. The 
intensity of colour is proportional to the amount of oxidized phenolic compounds and 
it can be estimated as gallic acid equivalents at 765nm.
71, 72 
 
Materials Required 
1. Ethanolic extracts of Ipomoea sepiaria 
2. Gallic acid 
3. 10% sodium carbonate solution 
4. Folin–Ciocalteu reagent  
 
Procedure 
 The total phenol content of various leaf extracts of Ipomea sepiaria was 
estimated using Folin–Ciocalteu reagent method. The various extracts (methanol, 
ethanol, acetone and aqueous) 0.1ml from 1mg/ml was transferred into separate test 
tubes. To this solution, Folin–Ciocalteu Reagent 0.5ml and 1ml of sodium carbonate 
were added and final volume was made up to 10ml with distilled water. The mixture 
was allowed to stand for 1 hour with intermittent shaking. The absorbance of the 
reaction mixture was measured at wavelength 765nm. A calibration curve was 
generated using absorbance reading of gallic acid at different concentrations (2, 4, 6, 
8, 10µg/ml). The reaction mixture without sample was used as the blank. The total 
phenolic content in the various extracts were expressed as milligrams of gallic acid 
equivalent per gram of extract (mg GAE/g) and the results were presented in table 
no:IX 
 48 
 
TABLE-IX 
Estimation of total phenol content in ethanolic extract of  
Ipomoea sepiaria. 
 
STANDARD 
 
TEST 
TOTAL 
PHENOL 
CONTENT 
 
 
 
Gallic 
acid 
Conc. 
in 
µg/ml 
Absorbance Exracts Conc 
in 
µg/ml 
Absorbance mg of GAE 
equivalent/gm of 
extract* 
I II III 
2 
4 
6 
8 
10 
0.148 
0.325 
0.502 
0.686 
0.931 
 
 
EEIS 
 
 
10 
 
 
0.156 
 
 
0.175 
 
 
0.154 
 
 
206.41±5.970 
*
-
mean of three readings ± SEM 
Fig: 1 CALIBRATION CURVE OF GALLIC ACID 
*
-
mean of three readings ± SEM 
Calibration curve of gallic acid
y = 0.0921x - 0.0284
R2 = 0.994
-0.2
0
0.2
0.4
0.6
0.8
1
0 2 4 6 8 10 12
Conc. in mcg/mL
A
b
so
rb
an
ce
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ESTIMATION OF TOTAL FLAVONOID CONTENT  
Principle 
 The total flavonoid content of various extracts were estimated by aluminum 
chloride colorimetric assay method. In this method, aluminum chloride complexes 
with standard and test sample (aluminum chloride complexes with flavonoids of C3-
C5 hydroxyl group) and to produce intense colour in acidic medium. The intensity of 
the colour is proportional to the amount of flavonoids and can be estimated as 
quercetin equivalents at wavelength of 415 nm.
73, 77
 
 
Materials Required 
1. Ethanolic extracts of Ipomea sepiaria  
2. 10% aluminum chloride 
3. 1M potassium Acetate 
4. 95% ethanol 
 
Procedure 
  About 0.5ml from 1mg/ml of ethanolic extract of Ipomoea sepiaria was 
transferred into separate test tubes. To this solution, 0.1 ml of aluminum chloride, 
0.1ml of potassium acetate and 1.5ml of 95% ethanol were added. The final volume 
was made up to 5ml with distilled water. The mixture was allowed to stand for 30min 
with intermittent shaking. The absorbance of reaction mixture was measured at 
415nm. A calibration curve was generated using absorbance readings of quercetin at 
different concentrations (5-50µg/ml). The reaction mixture without aluminium 
chloride was used as the blank. The total flavonoid content in the various extracts 
were expressed as milligrams of quercetin equivalent per gram of extract and the 
results were presented in table no: 10. 
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TABLE-X 
ESTIMATION OF TOTAL FLAVANOID CONTENT IN ETHANOLIC 
EXTRACT OF Ipomoea sepiaria 
 
STANDARD 
 
 
ABSORBANC
E AT 415 nm 
 
       TEST 
 
   ABSORBANCE 
TOTAL 
FLAVONOID 
CONTENT 
 
 
Sample 
 
Conc.in 
µg/ml 
 
 
 
Sample 
Conc 
in 
µg/m
l 
 
 
I 
 
 
II 
 
 
III 
mg   of quercetin       
Eq/gmof extract 
 
Quercetin 
 
2 
4 
6 
8 
   10 
 
0.589 
1.151 
1.710 
2.390 
3.112 
 
 
EEIS 
 
 
100 
 
 
 
0.256 
 
 
 
0.261 
 
 
 
0.258 
 
 
194.88 ± 1.54 
 
 
 
 
Mean of three readings ± SEM 
   Fig: 3 CALIBRATION CURVE OF QUERCETIN 
Calibration curve of quercetin
y = 0.0307x - 0.0432
R
2
 = 0.9974
-0.5
0
0.5
1
1.5
2
2.5
3
3.5
0 50 100 150
Conc. in mcg/mL
A
b
s
o
rb
a
n
c
e
Series1
Linear (Series1)
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SECTION –D 
ISOLATION AND CHARACTERIZATION OF FLAVONOIDS. 
98, 99,100
 
 Ethanolic extract of Ipomoea sepiaria was subjected to column 
chromatography for the isolation of phytoconstituents. 
 
MATERIALS REQUIRED 
Column  
Silica gel ( 60 -120 mesh size) 
Cotton 
Petroleum ether AR grade 
Ethyl acetate       AR grade 
Methanol AR grade 
Pre-Coated TLC plates 
PROCEDURE 
 Column chromatography was prepared by mixing 150 gm of silicagel in to a 
slurry with petroleum ether and pouring the mixture in to the glass column after the 
adsorbent settled. A cotton plug was kept on the top of the column so that the 
adsorbent layer is not disturbed during the introduction of the sample and mobile 
phase. 10 gm of ethanolic extract of Ipomoea Sepiaria was charged on the column 
and eluted successively by gradient elution technique with petroleum ether 
,ethylacetate,and methanol. About 20 ml of fractions were collected in a test tube and 
subjected to TLC in order to identify the presence of compounds. Fractions which 
gave the same Rf values were pooled together and it was subjected to TLC analysis 
for the confirmation of the presence of single compound  and the results were given in 
table-XI 
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    TABLE-XI 
ISOLATION OF PHYTOCONSTITUENTS FROM ETHANOLIC EXTRACT 
OF Ipomoea sepiaria BY COLUMN CHROMATOGRAPHY 
 
ELUENT 
 
FRACTION 
NUMBER 
 
 
NATURE      
OF RESIDUE 
 
EXAMINATION 
BY TLC 
 
NUMBER OF 
COMPOUNDS 
PE 100% 1-20 No residue No spots  No compounds 
PE:EA(80:20) 1-12 No residue No spots  No compounds 
 13-19 Pale green  Two spots Two compounds 
 20-35 No residue No spots  No compounds 
PE:EA (60:40) 1-21 No residue No spots  No compounds 
PE:EA(40:60) 1-20 No residue No spots  No compounds 
PE:EA (20:80) 1-22 No residue No spots  No compounds 
EA  (100%) 1-14 No residue No spots  No compounds 
 15-21 Pale green Single compound Single compounds 
 22-35 No residue No spots  No compounds 
EA:MeOH 
(80:20) 
1-23 Pale Yellow  Two spots Two compounds 
 
 
24-35 No residue No spots  No compounds 
EA:MeOH 
(60:40) 
1-20 No residue No spots  No compounds 
 
EA:MeOH 
(40:60) 
1-13 No residue No spots  No compounds 
 
EA:MeOH 
(20:80) 
1-16 No residue 
 
No spots  No compounds 
 
MeOH(100%) 1-19 No residue No spots  No compounds 
PE-Petether,     EA-Ethyl acetate,     MeOH-Methanol. 
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Fraction 13-19 of petroleum ether: ethylacetate (80:20) gave two spots on 
TLC and these fractions were evaporated to a residue which is called as mixture-I. 
Further elution with petroleum ether and ethyl acetate with increasing  the polarity 
was not given any compound. Fraction 15-21ofethyl acetate given a single spot on 
TLC and this fraction was evaporated to a residue which bears pale green colour and 
its called as compound-III. 
 
 Fraction 1-23 of Ethylacetate and methanol (80:20) gave two spots on TLC 
which was pale yellow in colour and these fractions were evaporated to a residue 
which was called as mixture-II. 
 
 Isolated mixtures such as mixture-I,mixture-II and single compound were 
given positive reaction for flavonoids by chemical test. Co-TLC examination of 
mixture II compounds with standard quercetin revealed the presence of quercetin in 
this mixture. 
  
PURIFICATION AND IDENTIFICATION OF MIXTURE OF COMPOUNDS 
BY PREPARATIVE THINLAYER CHROMATOGRAPHY: 
The mixture of Isolated compounds were isolated by preparative thinlayer 
chromatography using silica gel G as a stationary phase toluene: ethyl acetate: formic 
acid,(70:30:0.1) as a mobile phase, UV and ammonia as detecting agent.
74,75,76.
 (Fig-
13.1) 
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PREPARATION OF TLC PLATE: 
Preaparative TLC plates were prepared  for 2mm thickness using silica gel G 
as stationary phase by using mechanical spreader then the plates were activated at 
110ºc for 1 hour in an oven. 
 
 SAMPLE APPLICATION: 
The isolated compounds were applied on the preparative TLC plate in band 
form using capillary tube then the plates were placed in TLC chamber.  
 
VISUALISATION OF COMPOUND: 
TLC plates were visualized with UV and ammonia in order to identify the 
spots. Two spots were obtained from each mixture and these spots were scraped 
carefully to isolate the compounds and the scraped compounds along with silica gel 
was collected in a 50 ml beaker containing small volume of ethanol. it was filtered to 
remove the silicagel and the filtrate was evaporated to a residue then it was 
recrystalized with ethanol.  
 
    TABLE-XII 
                 PTLC OF MIXTURE COMPOUNDS  
   
 
 
 
 
 
 
 
   ISOLATED 
COMPOUNDS 
      PURIFIED 
PHYTOCONSTITUENTS 
   
    Rf  VALUES 
  
    MIXTURE-I  
Compound I 0.27 
Compound II 0.41 
 
    MIXTURE-II  
Compound IV 0.66 
Compound V 0.73 
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TABLE-XIII 
   CO-TLC AND TLC STUDIES OF ISOLATED COMPOUND 
Name of the compound Rf values Name of the standard Rf values 
Compound IV 0.66 Quercetin 0.66 
Compound III 0.56 ---- ---- 
           
 
FIG-13.1PREPARATIVE TLC OF MIXTURE I AND MIXTURE II 
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FIG-13.2 CO-TLC WITH QUERCETIN STANDARD 
 
These compounds were further characterized by IR spectrum 
TABLE- XIV 
 
COMPOUNDS 
                FUNCTIONAL GROUP IN cm-1 
PHENOLIC -OH  C-O Stretching        C === C 
COMPOUND-I 3342 cm-1 1392 cm-1 1598 cm-1 
COMPOUND-II 3601 cm-1 1445 cm-1 1592 cm-1 
COMPOUND-III 3601 cm-1 2927 cm-1 1594 cm-1 
COMPOUND-IV 3371 cm-1 1408 cm-1 1590 cm-1 
COMPOUND-V 3296 cm-1 2926 cm-1 1584 cm-1 
   
 Compound-I ,compound-II, compound-IV and V were isolated by preparative 
TLC . A single compound has already been identified as compound III,  These 
isolated compounds were given positive reaction for flavanoids.CO-TLC examination 
of compound IV with standard quercetin revealed that the compound IV may be 
quercetin. (Fig-13.2) 
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 CHAPTER-VI  
PHARMACOLOGICAL SCREENING 
SECTION-A 
IN VITRO ANTIOXIDANT ACTIVITY OF ETHANOLIC  EXTRACT OF  
Ipomoea sepiaria 
 
. Majority of the present day, diseases are due to the shift in the balance of pro-
oxidant and antioxidant. Pro-oxidant conditions dominate either due to the increased 
generation of the free radicals caused by excessive oxidative stress of the current life (or) If 
not effectively scanned by cellular constituents and depletion of the dietary antioxidant 
may leads to various disease conditions, such as rheumatoid arthritis, haemorrhagic shock, 
CVS disorders and neurodegenerative disease. 
            Antioxidants are vital substances which possess the ability to protect the body from 
damage caused by free radical induced oxidative stress. Oxidative stress causes various 
disease conditions such as ageing, anaemia, arthritis, asthma, inflammation, ischemia, 
neurodegeneration, Parkinson’s disease, and perhaps dementia. Phenolic hydoxyl group 
compounds may exert powerful antioxidant activity invitro by lipid peroxidase inhibitors or 
scavenging the free radicals. The antioxidant activity can be performed by various 
methods.  
 
a. DETERMINATION OF RADICAL SCAVENGING ACTIVITY AGAINST 
HYDROGEN PEROXIDE: 
PRINCIPLE: 
              The radical scavenging activity against hydrogen peroxide of plant extract was 
determined by using the method of Ruch et al. The principle based o the capacity of the 
extracts to decompose the hydrogen peroxide to water.
83 
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INSTRUMENT: 
             Shimadzu UV Visible spectrophotometer, Model 1800. 
REAGENTS: 
             6% hydrogen peroxide diluted with water in the ratio of 1:10. 
             0.1M,P
H
 7.4 phosphate buffer. 
PROCEDURE: 
             The ethanolic extract of Ipomoea sepiaria was dissolved in ethanol to get a stock of 
1mg/ml. Varying quantities of the stock solution was added to 3.8ml of 0.1M phosphate 
buffer solution (P
H
 7.4) and then mixed with 0.2ml of hydrogen peroxide solution. The 
absorbance of the reaction mixture was measured at 230nm after 10min.The mixture 
without sample was used as blank. Ascorbic acid was used as standard. The percentage 
inhibition of hydrogen peroxide was calculated using the formula %inhibition = (A control- 
A sample)/Acontrolx100.The results are present in Table. XV 
TABLE-XV 
HYDROGEN PEROXIDE RADICAL SCAVENGING ACTIVITY OF  
ETHANOLIC EXTRACT OF  Ipomoea Sepiaria 
S. No. Conc. in 
μg/mL 
    Percentage inhibition 
by standard Hydrogen 
peroxide 
Percentage      
inhibitionby 
EEIS 
1 20 18.81            34.75 
2 40 23.52 38.35 
3 60                 47.85 41.95 
4 80 72.18 44.49 
5 100 86.56 48.09 
 IC50 47.04 μg/ml 89.43 
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                Fig:14 Hydrogen peroxide scavenging activity of Ethanolic extract of 
 Ipomoea sepiaria 
        
 
 
 
 
 
 
 
 
 
b. DPPH  SCAVENGING (2, 2-diphenyl-1-picrylhydrazyl) ASSAY 
Principle 
 The free radical scavenging activity is measured by using DPPH assay. DPPH 
molecules are stable free radicals that contain unpaired electron. The quantitative 
estimation of free radical scavenging activity is determined according to Blois et al 
method. When the solution of DPPH is mixed with substance that can donate a hydrogen 
atom, it is converted to its reduced form which is indicated by the colour changes from 
deep violet to pale yellow colour. The result of the antioxidant activity is expressed as EC50 
or IC50. 
Materials required 
1. Ethanolic leaf & Stem extract of Ipomoea sepiaria 
2. DPPH 
3. 95% ethanol 
4. Ascorbic acid  
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Procedure  
  The DPPH solution (0.1mM) in ethanol was prepared and 1.0ml of this solution was 
added to 3.0 ml of extract solution (or standard) in water of different concentrations (10-50 
µg/ml). Thirty minutes later, the absorbance was measured at 517 nm. Lower absorbance of 
the reaction mixture indicates higher free radical scavenging activity. Scavenging of DPPH 
radical was calculated using the following equation. 
 
 % inhibition = A0-A1/A0 × 100 
Where            A0-The absorbance of the control reaction 
           A1- The absorbance of the test sample 
 IC50 (concentration providing 50% inhibition) was calculated graphically using a 
calibration curve by plotting the extract concentration Vs % inhibition. The mean values 
were obtained from triplicate experiments. 
 
TABLE-XVI 
       DPPH RADICAL SCAVENGING ACTIVITY OF ETHANOLIC EXTRACT OF               
Ipomoea Sepiaria 
   Values are expresses mean ± SEM (n=3) 
Conc.µg/ml  STANDARD   %inhibition EEIS %inhibition 
 
10 39.94 
 
30.69 
 
20 47.05 
 
36.76 
 
30 70.94 
 
39.12 
 
40 88.98 
 
41.82 
 
50 96.94 
 
43.50 
 
IC50 values 17.9625 µg/ml 
 
99.80 µg/ml 
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                FIG:15 Hydrogen peroxide scavenging activity of Ethanolic extract of 
 Ipomoea sepiaria 
 
                 
 
TABLE-XVII 
DPPH ANTIOXIDANT ACTIVITY OF ISOLATED COMPOUNDS 
 
Conc.µg/ml 
 STANDARD   
%inhibition 
MIXTURE-I 
COMPOUND 
MIXTURE-II 
COMPOUND 
SINGLE 
COMPOUND 
10 39.94 
 
12.32        48.77 22.65 
20 47.05 
 
25.13 53.14 31.34 
30 70.94 
 
37.55 62.55 45.44 
40 88.98 
 
50.33 69.94 56.11 
50 96.94 
 
64.55 81.53 68.43 
IC50 values 17.9625 µg/ml 
 
      77.23 µg/ml    46.13 µg/ml   69.43 µg/ml 
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Fig:16 DPPH scavenging activity of Isolated mixture-I 
 
    
 
 
                         Fig:17 DPPH scavenging activity of Isolated mixture-II  
 
               
63 
 
 Fig:18 DPPH scavenging activity of isolated Single compound         
 
 
 
Mixture II exhibited significant antioxidant activity than mixture I and single compound,   
mixture two contains flavonoids evaluated against acrylamide induced neuropathic pain in 
rats.        
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SECTION-B 
PHARMACOLOGICAL EVALUATION OF Ipomoea Sepiaria ON ACRYLAMIDE 
   INDUCED NEUROPATHIC PAIN IN RATS
 78,80,81,82,94,95
 
Neuropathic pain associated with peripheral nerve injury which is characterized by 
the sensory abnormalities such as unpleasant and abnormal sensation (dysesthesia), an 
inceased response to painful stimuli (hyperalgesia), and pain in response to a stimulus that 
does not normally provoke pain (allodynia) According to ethanomedical claim leaf 
decoction of Ipomoea sepiaria is used for nervous disorders. Hence the Ethanolic extract of 
Ipomoea sepiaria has been evaluated for acrylamide induced painful neuropathy in rats. 
 
Materials and Methods 
Plant  Material   
Ethanolic leaf extract of Ipomoea sepiaria, [EEIS] 
Animals   
Wistar rats (either sex, 150-200gm) were employed in the present study. Animals 
were maintained at laboratory diet and allow to free access to water ad libitum. They were 
housed in the animal house and exposed to normal cycle of light and dark. The 
experimental protocol was duly approved by the  institutional animal ethical committee and 
animals were maintained as per CPCSEA guideline. (Committee for the purpose of control 
and supervision of experiments on Animals Ref no:14024/E1/4/2011 ) of the Dean, 
Madurai medical college, Madurai. 
 
Chemicals    
Acrylamide was purchased from CDH, chemicals New Delhi. All other chemicals 
used for this study were of analytical grade. 
Induction of Neuropathic pain  
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The Acrylamide 30mg/kg was administered by intraperitonially once in three days, 
for 24 consecutive days to induce painful neuropathy. All the groups of animals were 
subjected to sensory behavioral tests such as paw cold allodynia, hot plate test, and tail 
immersion test  in order to assess the degree of nociceptive threshold on certain day 
intravels, ie.0,3, 6,9, 12,15, 19,21 & 24
th
day. 
 
Experimental Design  
Six groups, each comprising six Wistar rats, were employed in the present study. 
 
Group I (Normal control group) 
 Rats were not subjected to administration of vehicle and acrylamide and were kept 
for 24 days. Behavioural tests were employed to assess nociceptive threshold on different 
day’s i.e. 0,3, 6,9, 12.15,19,21 & 24th. All the animals were sacrificed according to 
CPCSEA guidelines at the end of the 24
th
 day. Sciatic nerve of the animals were isolated 
and homogenated to estimate biochemical markers such as TBARS, reduced glutathione, 
total protein and total calcium levels. Histopathological studies also carried out with the 
distal portion of the sciatic nerve. 
 
Group II (Acrylamide 30mg/kg, i.p) 
Acrylamide (30mg/kg, i.p) was administered to normal rats once in three days for 
24 consecutive days. Behavioural tests and Biochemical parameters were assessed as 
described in group I. 
 
Group III  (Ethanolic extract of EEIS 100mg/kg treated group) 
Ethanolic leaf extract of Ipomoea sepiaria 100mg/kg, p.o was administered two 
hours before each acrylamide injection (acrylmide was administered once in three days) for 
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24 consecutive days. Behavioural tests and Biochemical parameters were assessed as 
mentioned in group I. 
 
Group I V (Ethanolic extract of EEIS 200mg/kg treated group) 
Ethanolic leaf extract of Ipomoea sepiaria 200mg/kg,p.o, was administered two 
hours before each acrylamide injection (Acrylmide was administered once in three days) 
for 24 consecutive days. Behavioral tests and Biochemical parameters were assessed as 
mentioned in group I. 
 
Group V ( Isolated compound (mixture-II) of EEIS 5mg/kg treated group) 
Ethanolic leaf extract of Ipomoea sepiaria 5 mg/kg,p.o was administered two hours 
before each acrylamide injection (Acrylmide was administered once in three days) for 24 
consecutive days. Behavioural tests and Biochemical parameters were assessed as 
mentioned in group I. 
 
Group VI (Pregabaline 10mg/kg, treated group) 
Pregabaline (10mg/kg, p.o) was administered two hours before each acrylamide 
injection (acrylmide was administered once in three days) for 24 consecutive days. 
Behavioral tests and Biochemical parameters were assessed as mentioned in group I. 
 
SENSORY BEHAVIOURAL ASSESMENT 
Paw cold allodynia 
 Cold allodynia of the hind paw was assessed using acetone drop method as 
described by Choi et al (1994) with slight modification,  Assessing the reactivity to non-
noxious cold chemical stimuli.the rats were placed on the top of  a wire mesh grid allowing 
access to the hind paw.Acetone(0.1ml) was sprayed on the plantar surface of hind paw of 
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rat and time taken for the withdrawl of the hind paw from the mesh surface was noted ,with 
cut-off time of 60 seconds. 
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Hot plate test 
 Heat thermal sensitivity of the hind paw was assessed by using Eddy’s hot plate as 
described method of Eddy et at, with slight modification for assessing the degree of 
noxious thermal sensation. The rats were placed on the top of a preheated (52 ± 0.5ºc) hot 
plate surface, allowing access to the hind paw withdrawal response to degree of the 
nociceptive threshold. The cut- off time of 20 seconds was maintained.
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Tail immersion test 
 Tail immersion test was carried out to assess the spinal heat thermal sensitivity. Tip 
of the rat’s tail was immersed in heat noxious temperature (52 ± 0.05ºc) till the tail was 
withdrawn. Thermal heat hyperalgesia was assessed by duration of the tail withdrawal 
reflex. The cut off time of 10 s was maintained.
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Biochemical estimation of markers of oxidative stress 
              All the groups of animals were sacrificed after 24
th 
days by cervical dislocation 
and the sciatic nerve was isolated immediately and used for the biochemical estimation. 
The distal most part of the nerve, which was used for histopathological study. Freshly 
excised sciatic nerve homogenate (10%) was prepared with 0.1M Tris Hcl buffer(PH-7.4) 
and the homogenate was kept in ice water for 30 min and centrifuged at 4ºc (2000g, 10 
min). The supernatant of homogenate was separated and which was used to estimate 
following biochemical markers.
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Estimation of total protein content 
          The protein concentration was estimated according to the method of Lowry et al
 
s
using bovine serum albumin as a standard. The absorbance was determined 
spectrophotometrically at 750nm.
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 Estimation of total calcium  
           Total calcium level was estimated in sciatic nerve as described method of 
Severtnghaus and Ferrebee and Muthuraman.Total calcium level was estimated in sciatic 
nerve. The sciatic nerve homogenate was mixed with 1ml of trichloroacetic acid (4%) as in 
ice cold condition and centrifuged at 1500g for 10 mins. The clear supernatant was used for 
the estimation by atomic emission spectroscopy at 556 nm.
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Estimation of reduced glutathione 
 Equal quantity of sciatic nerve homogenate was mixed with 10% trichloroacetic 
acid and the mixture was centrifuged to separate proteins. To 0.01ml of this supernatant, 
2ml of phosphate buffer (PH-8.4), 0.5ml of 5, 5’ dithiobis (2-nitrobenzoic acid) and 0.4ml 
of distilled water were added. Mixture was vortexed and the absorbance was taken at 
415nm within 15mins. The concentration of reduced glutathione was expressed as µg/mg 
of protein.
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Estimation of TBARS 
The thiobarbituric acid reactive substances (TBARS) level was estimated as per the 
spectrophotometric method described by Ohkawa et al method, To each test tube, 0.5 ml of 
supernatant,0.5 ml normal saline,1 ml of 20% trichloroacetic acid (TCA) and 0.25 ml of 
TBA reagent (200 mg of thiobarbituric acid in 30 ml distilled water and 30 ml of acetic 
acid) were added. The test tubes were kept for boiling at 95º C for one hour. To each test 
tube, 3 ml of n-butanol was added and mixed well. These test tubes were centrifuged at 
3000rpm for 10 minutes. The separated butanol layer was collected and read in a 
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spectrophotometer against blank at 535 nm. Concentration of thiobarbituric reactive 
substances was expressed in terms of nmol of malondialdehyde per mg of protein.
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TABLE-XVIII  
Effects of Ethanolic extract of Ipomoea sepiaria on tissue biochemical changes 
Groups 
TBARS 
(nmol/mg of protein) 
GSH 
(µg/mg of protein) 
Total calcium 
(ppm/mg of protein) 
Normal 13.20 ± 0.23 69.37 ± 2.53 1.93 ± 0.79 
Acrylamide 56.41 ± 0.70 
a
 12.64 ± 3.15
 a
 16.87 ± 1.31
 a
 
EEIS (100 mg/kg) 29.2 ± 0.82
 b
 31.78 ± 2.96
 b
 7.16 ± 1.04
 b
 
EEIS (200 mg/kg) 21.2 ± 0.85 
b
 54.63 ± 3.94
 b
 5.48 ± 1.17
 b
 
EEIS-C (5 mg/kg) 20.55 ± 0.33
 b
 59.51 ± 2.76
 b
 3.64 ± 0.95 
b
 
Pregabalin 15.13 ± 0.51
 b
 61.64 ± 3.36
 b
 2.72 ± 0.86 
b
 
Data were expressed as mean ± SD (n=6). 
EEIS,(Ethanolic extract of ipomoea sepiaria); EEIS-C,(Ethanolic extract of ipomoea 
sepiaria isolated compound); 
a
P < 0.05 Vs. normal group. 
b
P < 0.05 Vs. acrylamide control group. 
Digits in parentheses indicate dose in mg/kg. 
TBARS-Thiobarbituric acid reactive substance; GSH-Reduced glutathione; Ipomoea 
sepiaria,  
Histopathological examination 
Samples of sciatic nerve were fixed with 10% formalin and cut in to sections with 
4µm thickness, staining was done by using haematoxylin and eosin. Nerve sections were 
analysed qualitatively under light microscope (45x) for axonal degeneration and fibres 
dearrangements.Effect of Ipomoea sepiaria on acrylamide induced histopathological 
changes were shown in Fig-19 to 23. 
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Fig-19 NORMAL CONTROL GROUP-I 
  
Fig-20 ACRYLAMIDETREATEDGROUP-II       
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Fig-21 EEIS TREATMENT 100 mg/kg GROUP-III 
 
                          
Fig-22 EEIS TREATMENT 200 mg/kg GROUP-IV 
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Fig-23 EEIS ISOLATED COMPOUND TREATMENT 5 mg/kg GROUP-V 
 
 
Fig 19-23 shows cross section of sciatic nerve of normal acrylamide, EEIS 100 mg, 200 mg 
and 5 mg/kg.p.o,  Treated groups respectively. Fig-19 showed normal histopathology of 
sciatic nerve, In fig-20 shows acrylamide induced axonal degeneration and dearrangement 
of nerve fibres. Fig-21,  22 and 23 pretreatment of Ipomoea sepiaria showed decrease in 
the acrylamide induced histopathological changes of sciatic nerve. 
 
Statiscal analysis 
All the results were expressed as standard error of mean (SEM). Data obtained from 
behavioural tests were statistically analysed by using two-way repeated ANOVA, while 
data of biochemical parameters were analysed using one way ANOVA. In both cases, 
Tukey’s multiple range tests were applied for post-hoc analysis. A value of p<0.05 was 
considered to be statistically significant.    
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SECTION-C 
IN VITRO ANTI CANCER ACTIVITY 
The human liver cancer cell line (HepG2) was obtained from National Centre for 
Cell Science (NCCS), Pune, and grown in Eagles Minimum Essential Medium containing 
10% fetal bovine serum (FBS). All cells were maintained at 37
0
C, 5% CO2, 95% air and 
100% relative humidity. Maintenance cultures were passaged weekly, and the culture 
medium was changed twice a week,Ethanolic extract of ipomoea sepiaria was used in five 
different concentrations such as 31.25µg,62.5 µg,125 µg,250 µg, and 500 µg.
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CELL TREATMENT PROCEDURE 
 The monolayer cells were detached with trypsin-ethylenediaminetetraacetic 
acid (EDTA) to make single cell suspensions and viable cells were counted using a 
hemocytometer and diluted with medium with 5% FBS to give final density of 1x10
5
 
cells/ml. one hundred microlitres per well of cell suspension were seeded into 96-well 
plates at plating density of 10,000 cells/well and incubated to allow for cell attachment at 
37
0
C, 5% CO2, 95% air and 100% relative humidity. After 24 h the cells were treated with 
serial concentrations of the extracts and fractions. They were initially dissolved in neat 
dimethylsulfoxide (DMSO) and further diluted in serum free medium to produce five 
concentrations. One hundred microlitres per well of each concentration was added to plates 
to obtain final concentrations of 31.25µg,62.5 µg,125 µg,250 µg, and 500 µg, The final 
volume in each well was 200 µl and the plates were incubated at 37
0
C, 5% CO2, 95% air 
and 100% relative humidity for 48h. The medium containing without samples were served 
as control. Triplicate was maintained for all concentrations. 
 
 
 
 
74 
 
MTT ASSAY 
 MTT is a yellow water soluble tetrazolium salt. A mitochondrial enzyme in living 
cells, succinate-dehydrogenase, cleaves the tetrazolium ring, converting the MTT to an 
insoluble purple formazan. Therefore, the amount of formazan produced is directly 
proportional to the number of viable cells. 
 
 After 48h of incubation, 15µl of MTT (5mg/ml) in phosphate buffered saline (PBS) 
was added to each well and incubated at 37
0
C for 4h. The medium with MTT was then 
flicked off and the formed formazan crystals were solubilized in 100µl of DMSO and then 
measured the absorbance at 570 nm using micro plate reader. The % cell inhibition was 
determined using the following formula. 
  
% cell Inhibition = 100- Abs (sample)/Abs (control) x100.  
 
Nonlinear regression graph was plotted between % Cell inhibition and Log10 
concentration and IC50 was determined using GraphPad Prism software. 
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Fig- 24: CONTROL 
 
 
 
Fig 25: 31.25 µg OF ETHANOLIC EXTRACT OF Ipomoea sepiaria ON LIVER       
                                                CANCER CELLS 
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Fig-26: 62.5 µg OF ETHANOLIC EXTRACT OF Ipomoea sepiaria ON LIVER       
                                                CANCER CELLS 
 
 
 
Fig-27: 125 µg OF ETHANOLIC EXTRACT OF Ipomoea sepiaria ON LIVER       
                                                CANCER CELLS 
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Fig 28: 250 µg OF ETHANOLIC EXTRACT OF Ipomoea sepiaria ON LIVER       
                                                CANCER CELLS 
 
 
 
Fig-29: 500 µg OF ETHANOLIC EXTRACT OF Ipomoea sepiaria ON LIVER       
                                                CANCER CELLS 
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     TABLE-XIX 
ETHANOLIC  EXTRACT OF Ipomoea Sepiaria on HepG2 (LIVER CANCER )     
    CELL LINES                
HepG2               
  Conc 
31.25 
µg 62.5 µg 125 µg 250 µg 500 µg Cont 
  ABS 0.428 0.408 0.255 0.144 0.052 0.455 
    0.419 0.411 0.242 0.148 0.037 0.432 
    0.433 0.396 0.265 0.11 0.04 0.453 
S  Avg 0.426 0.405 0.254 0.134 0.043 0.446 
 
 
                        IC 50             156.1 ug/ml 
                                    R²       0.9926 
 
   
 
   
 
Conc of 
EEIS 
(µg) 
% Cell 
Inhibition 
31.25 4.47 
62.5 9.32 
125 43.13 
250 70.01 
500 90.37 
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CHAPTER-VII 
RESULTS AND DISCUSSION 
 This dissertation covers the works on pharmacognostic, phytochemical and 
pharmacological studies on the leaves of Ipomoea sepiaria   belongs to the family 
convulvulaceae. 
 
CHAPTER-I 
 Introduction of this dissertation gives the  information about the antioxidant 
approach of herbal medicine, neuropathy and its etiology,causes of neuropathy 
pathophysiology, and hepatocellular carcinoma including herbal medicine cures for 
both neuropathy and hepatocellular carcinoma . Acrylamide as a neurotoxin to induce 
neuropathic pain and animal models of neuropathic pain were also discussed in this 
chapter. 
 
CHAPTER-II 
 Literature survey pertaining to the pharmacognostic, phytochemical and 
pharmacological studies and ethanomedical information of Ipomoea sepiaria were 
given in this chapter. 
 
CHAPTER-III 
 Aim and scope of the dessertation  have been discussed in this part of the 
study. 
CHAPTER-IV 
Pharmacognostic studies 
  Pharmacognostic standards for the leaves of Ipomoea sepiaria  which includes 
the macroscopical, microscopical, quantitative microscopy and physical standards 
were discussed in this chapter. 
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 Section-A 
 Scientific classification, synonym, vernacular names,geographical distribution, 
Habit and Habitat of the plant, and morphological characters of leaves, Flowers, fruits 
and seeds of this plant were dealt in this part of the study,  
 
Salient features of the macroscopy of leaves were observed, such as simple, 
alternate, margin is entire and the shape is ovate. Leaflet venations are reticulate and 
the leaves are dark green in colour having 1.5 inch long. 
 
Section-B 
 It deals with the microscopical studies of the leaves to find out the 
arrangement of tissues,     
   
The important anatomical features observed in the leaves of Ipomoea sepiaria are 
as follows.                    
 The stomata are exclusively paracytic type.Each stoma has two   subsidiary 
cells lying parallel to the guard cells. The stomata are elliptical in shape 
measuring 20x30µm in size. 
 The venation pattern is less densely reticulate and the veins are thin and 
undulate.  
 The vein terminations are long,slender,curved and simple. Most of the 
terminations bud in a cluster of terminal-tracheids (fig.7.2). The tracheids are 
rectangular and square shaped with spiral thickenings. 
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The following anatomical characters were observed with powder microscopy of 
leaves reveal the presence of, 
 Glandular trichomes are present along with epidermal cells which consist of a 
circular plate of glands comprising about eight triangular cells. 
 The stomata are paracytic type and the subsidiary cells are mostly unequal in 
size (fig.12.2). The surface of the cells appear finely dotted cuticular 
markings. (fig.10.1,2.11.1,2) 
 
Section-D 
 This part of study deals with the determination of leaf constants,  such as vein-
islet number, vein termination  number, stomatal number and stomatal index, The  
results were presented in table. 
      LEAF CONSTANTS 
 
 
 
 
   
 
 
 
 
 
Section-E 
 Physical parameters like profile of ash values, loss on drying and various 
extractive values have been determined for this plant which are given below.  
 
Content 
Leaves 
Min Ave Max 
Vein islet No 7 8 10 
Vein termination No 6 8 9 
Stomatal number 23 29 34 
Stomatal index 5.88 11.46 17.95 
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                                               PHYSICAL PARAMETERS 
 
 
 
 
  
 
    EXTRACTIVE VALUES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Highest extractive value was noted in 70 ethanolic extractive (19.36%)and the lowest 
extractive value was observed in Petroleum ether (4.95%).     
 
Content Leaves and stem 
% w/w 
Min Ave Max 
Total ash 14.92 15.69 16.88 
Acid insoluble 
ash 
5.65 6.55 6.82 
Water soluble 
ash 
9.83 6.82 10.14 
Loss on drying  5.92 6.26 6.45 
S.NO Solvents used Extractive 
values %  
1 Petroleum ether 4.95 
2 Chloroform 7.68 
3 Ethyl acetate 8.12 
4 Acetone 10.80 
5 Methanol 16.61 
6 Ethanol 7.12 
7 70% Ethanol 19.36 
8 Aqueous 10.76 
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CHAPTER-V 
Section-A 
               This part dealt with the organoleptic evaluation of the Ipomoea sepiaria 
which indicates that the powder material is green in colour, highly characteristic 
odour and mild astringent taste. 
 
Section-B 
                 Preliminary qualitative phytochemical examination of the powdered leaf 
and stem were carried out and the results were tabulated in table no-VII. This study 
indicates the presence of sterols, carbohydrates, proteins, flavonoids, terpenoids, 
tannins, and saponins. 
 
                 Preliminary phytochemical screening was also carried out with EEIS. It 
reveals that  ethanolic extract consists of flavonoids, tannins and saponins and the 
results were tabulated in the table no: VIII 
 
Section-C 
              This part of the study concerned with preparation of  70% ethanolic extract 
which was subjected to the estimation of total phenolic content,and flavonoid content. 
Preliminary phytochemical studies revealed the presence of Phenolic and flavanoids 
in this extracts. Hence this extract was estimated quantitatively for totalphenolic, and  
total falvonoid content and the results were shown in the following table. 
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This study revealed that the ethanolic extract showed significant phenolic and 
flavonoid content. 
 
Section-D 
ISOLATION AND CHARACTERIZATION OF FLAVONOIDS               
The dried extract of Ipomoea Sepiaria was subjected to column 
chromatography for the isolation of phytoconstituents. Purification and identification 
of these compounds were performed by preparative TLC and IR spectrum.  
 
Two mixtures such as mixture-I (pet ether:ethylacetate 80:20) mixture-II  
(ethylacetate:methanol 80:20) and a single compound (ethylacetate 100%) were 
obtained as eluates. One compound in mixture-II was identified as quercetin by CO-
TLC studies, These two mixtures, mixture-I and mimixture-II were further purified by 
preparative thinlayer chromatography (PTLC FIG-13.1) and each of these mixture 
gave two compounds viz compound-I,compound-II,compound-IV and V. 
 
These isolated compounds were given positive reaction for flavonoids, Isolated 
compound IV in mixture-II was also identified. 
 
 Chemical test for flavanoids,CO-TLC studies (Fig-13.2) and IR spectroscopy 
of compound IV revealed that the compound may be quercetin. Compound-I,II,III and 
V were identified as flavanoids by chemical tests and IR spectral studies. 
 
 
NAME OF 
EXTRACT 
TOTAL PHENOLIC 
CONTENT mg/g of extract 
TOTAL FLAVONOID 
CONTENT mg/g of extract 
 
EEIS 
 
206.41±5.970 
 
194.88± 1.54 
 
85 
 
CHAPTER-VI 
                     This part of the study deals with the pharmacological evaluation of 
ethanolic extract of Ipomoea sepiaria for antioxidant and acrylamide induced painful 
neuropathy in rats. 
 
SECTION-A 
INVITRO ANTIOXIDANT ACTIVITY OF ETHANOLIC EXTRACT OF                     
Ipomoea sepiaria BY DPPH METHODS 
H2O2  and DPPH antioxidant scavenging activity were carried out for EEIS 
and the results were tabulated in table no XIII & XIV. 
 
 
INVITRO ANTIOXIDANT ACTIVITY OF EEIS  BY HYDROGENPEROXIDE  
METHOD 
Ethanolic extract was evaluated for H2O2 assay which was revealed that the 
ethanolic extract at 100 µg/ml showed the absorbance of 48.09 %  where as the 
absorbance of standard drug was 86.56%. An increase in absorbance indicates that 
enhanced reducing potential of ethanolic extract. H2O2 assay also indicate the 
significant antioxidant activity of this extract.  
 
INVITRO ANTIOXIDANT ACTIVITY OF EEIS  BY DPPH METHOD 
Free radical scavenging activity of ethanolic extract of Ipomoea sepiaria 
(50µg/ml) was found to be 43.50 % when compared to the radical scavenging activity 
of standard drug vitamin-C which was found to be 96.94 %. IC 50 value of the 
ethanolic extract was 99.80µg/ml and for standard drug (vit-C) 17.96255 µg/ml. This 
study  indicate antioxidant activity of this extract. 
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INVITRO ANTIOXIDANT ACTIVITY OF ISOLATED COMPOUNDS OF                     
Ipomoea sepiaria BY DPPH METHOD 
Isolated compounds obtained by column chromatography such as mixture-I, 
mixture-II and single compound were evaluated for antioxidant activity by DPPH 
radical scavenging method. Mixture-II exhibited potent antioxidant activity 
(64.56µg/ml )when compare to mixture-I (170.81 µg/ml) and single compound 
(135.10 µg/ml ). Neuroprotective activity of flavonoids against toxin induced 
neuropathy was attributed due to their antioxidant potential.
101
 This study revealed 
that mixture-II exhibited significant antioxidant activity than mixture-I and single 
compound.Hence mixture-II was administered to the rats (5mg/kg body weight) in 
order to evaluate its efficacy against acrylamide induced painful neuropathy. 
 
Section-B 
Effect of EEIS on Paw cold allodynia 
Acrylamide induced toxicity of Sciatic nerve resulted significant development of non-
noxious cold chemical allodynia, noted by decrease in hind paw withdrawal threshold 
after 6
th
 day of acrylamide intoxication as compared to normal control group. 
Acrylamide induced, decrease in nociceptive threshold for cold allodynia was 
improved by the administration of EEIS (100&200mg/kg, p.o) and Isolated  mixture 
compound-II (5mg/kg,p.o) . Treatment of pregabalin also produced similar effects. 
However statistically significant attenuation was recorded   in all the groups treated 
with EEIS (100 & 200mg/kg,p.o, P < 0.05) and Isolated  mixture compound-II 
(5mg/kg,p.o P < 0.05).  
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Effect of EEIS on paw heat  hyperalgesic test  
               Acrylamide induced toxicity of Sciatic nerve resulted significant 
development of noxious thermal hyperalgesia noted by decrease in hind paw 
withdrawal threshold after 6
th
 day of acrylamide intoxication as compared to normal 
control group. Acrylamide induced, decrease in nociceptive threshold for thermal 
hyperalgesia  was improved by the administration of EEIS (100&200mg/kg, p.o) and 
Isolated  mixture compound-II (5mg/kg,p.o) . Treatment of pregabalin also produced 
similar effects. However statistically significant attenuation was recorded in all the 
groups treated with  EEIS (100 & 200mg/kg, p.o, P < 0.05) and Isolated  mixture 
compound-II (5mg/kg, p.o  P < 0.05 ). 
 
Tail immersion test 
   Acrylamide induced toxicity of Sciatic nerve resulted significant development of 
noxious thermal hyperalgesia noted by decrease in tail withdrawal threshold after 6
th
 
day of acrylamide intoxication as compared to normal control group. Acrylamide 
induced, decrease in nociceptive threshold for thermal hyperalgesia  was improved by 
the administration of EEIS (100&200mg/kg, p.o) and Isolated  mixture compound-II 
(5mg/kg,p.o).Treatment of pregabalin also produced similar effects. However 
statistically significant attenuation was recorded  in all the groups treated with both 
EEIS (100 & 200mg/kg, p.o) and Isolated  mixture compound-II (5mg/kg,p.o P < 
0.05). 
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Fig.30. Effect of Ethanolic extract of Ipomoea sepiaria by paw cold allodynia 
 
 
 
Data were expressed as mean ± SD (n=6). 
EEIS,(Ethanolic extract of ipomoea sepiaria); EEIS-C,(Ethanolic extract of ipomoea 
sepiaria isolated compound)    
a
P < 0.05 Vs. normal group. 
b
P < 0.05 Vs. acrylamide control group. 
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Fig.31. Effect of Ethanolic extract of Ipomoea sepiaria on hot plate test 
 
 
 
 
Data were expressed as mean ± SD (n=6). 
EEIS,(Ethanolic extract of ipomoea sepiaria); EEIS-C,(Ethanolic extract of ipomoea 
sepiaria isolated compound); 
a
P < 0.05 Vs. normal group. 
b
P < 0.05 Vs. acrylamide control group. 
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Fig.32. Effect of Ethanolic extract of Ipomoea sepiaria on tail immersion test 
 
 
 
Data were expressed as mean ± SD (n=6). 
EEIS,(Ethanolic extract of ipomoea sepiaria); EEIS-C,(Ethanolic extract of ipomoea 
sepiaria isolated compound) 
a
P < 0.05 Vs. normal group. 
b
P < 0.05 Vs. acrylamide control group. 
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Effect of EEIS on oxidative stress markers 
 Acrlyamide induced sciatic nerve intoxication resulted in significant rise in 
TBARS,(56.41nmol,p<0.05) total calcium level (16.87ppm,p<0.05) and decrease in 
the level of reduced glutathione (12.64 µg/mg,p<0.05) after the 24
th
 day of drug 
administration as compared to normal control group. Administration of EEIS and  
isolated mixture compound attenuated acrylamide induced rise in sciatic nerve tissue 
level of TBARS and total calcium, and the decreased level of reduced glutathione.  
Administration of EEIS (100 mg/kg., p.o) resulted attenuation of TBARS ( 29.2 nmol, 
p<0.05) and total calcium ( 7.16  ppm, p<0.05) and rise in the level of reduced 
glutathione (31.78µg/mg,p<0.05). EEIS treatment (200mg/kg., p.o)  resulted the 
reduction of TBARS ( 21.2 nmol, p<0.05) and total calcium ( 5.48  ppm, p<0.05) and 
increased in the level of reduced glutathione (54.63 sµg/mg,p<0.05). Administration 
of isolated mixture compound-II (5 mg/kg.p.o) was found to be decreased TBARS ( 
20.55 nmol, p<0.05) and total calcium ( 3.64  ppm, p<0.05) and elevated the level of 
reduced glutathione (59.51µg/mg,p<0.05). 
 
Effect of histopathological changes 
  Acrylamide induced toxicity of sciatic nerve resulted in significant 
histopathological changes assessed in cross section of the sciatic nerve. In the cross 
section, acrylamide induced axonal degeneration and dearrangement of nerve fibres 
were observed. Administration of EEIS and isolated mixture compound-II 
(100mg,200mg & 5 mg/kg, p.o) significantly attenuated acrylamide induced axonal 
degeneration and dearrangement of nerve fibres. 
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Discussion  
 In the present study, EEIS and isolated mixture compound-II treatment 
normalize acrylamide induced sciatic nerve intoxication mediated behavioural (heat 
hyperalgesia [paw & tail ], cold allodynia) and biochemical abnormalities (TBARS, 
total calcium & reduced glutathione). Acrylamide toxicity causes the “dying back” 
neuropathy in rats (distal axonopathy). Acrylamide is a neurotoxic agent, is used in 
industries which involved in the manufacture of dye and fibre, polymer production, 
gel electrophoresis and water treatment. Acrylamide exposure leads to central-
peripheral distal axonopathy in peripheral nervous system. 
 
 The underlying mechanism for the cause of acrylamide intoxicated 
neuropathy is still not yet understood. Recently oxidative stress has been 
demonstrated to be one of the key mechanism in many chemical- induced cell 
injuries. Oxidative stress in the cells or tissues refers to enhanced generation of ROS 
and/or depletion of antioxidant defense system, causing an imbalance between pro 
oxidants and antioxidants, potentially leading to damage.  
 
 If the intracellular reactive oxygen species level increases may lead to damage 
the mitochondria, lipid peroxidation, elevated cytokine production and cell death. 
ROS generation in tissues is effectively scavenged by enzymatic antioxidant system, 
(such as SOD, GSH-Px, CAT, and GR) and non enzymatic antioxidants (such as 
GSH, Vitamin A, C, and E). This present study revealed that TBARS level of the 
acrylamide treated group was found to be elevated and it was found to be decreased 
significantly in EEIS (100mg/kg 200mg/kg; P < 0.05) and isolated mixture compound 
(5mg/kg; P < 0.05) treated animals.  
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These findings indicate that acrylamide induced lipid peroxidation denoted by 
elevated TBARS level was markedly controlled by EEIS treatment at 100mg,200mg 
& isolated mixture compound 5mg/kg, p.o. Documented studies revealed that ROS 
can attack the polyunsaturated fatty acid in the biomembrane to initiate the free 
radical chain reaction.  
 
Acrylamide treatment significantly reduces the non enzymatic endogenous 
antioxidant GSH level and the EEIS treatment 100mg,200mg & isolated mixture 
compound 5mg/kg, p.o significantly increases the level of GSH. The above data 
indicate that EEIS treatment resulted elevation of endogenous antioxidant GSH. GSH 
which can effectively scavenge free radicals directly and indirectly which is the major 
non enzymatic antioxidant in cells.  
 
GSH plays an important role in antioxidant defense, nutrient metabolism, and 
regulation of cellular events. GSH deficiency contributes to oxidative stress, which 
takes effect in the pathogenesis of many diseases, e.g., Alzheimer’s disease and 
neuropathy. 
 
 Documented studies showed that conjugation with glutathione (GSH) is a 
mechanism for the detoxification of acrylamide. Glycidamide, an active neurotoxic 
metabolite of acrylamide, can also conjugate with GSH. The acrylamide induced 
depletion of GSH may make the nerve tissue more sensitive to the oxidative stress 
which is significantly reversed by EEIS treatment.  
 
Acrylamide treatment increases total calcium level and treatment of EEIS at 
100mg/kg, 200mg/kg and isolated mixture compound 5mg/kg, significantly reduces 
the total calcium level. The noted decrease in calcium level with EEIS may be 
attributed to its antioxidant effect, as free radicals are well reported to increase 
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calcium ions. However the possible action of EEIS on decrease in calcium level may 
not also be ruled out. Moreover increase in calcium ions is also associated with 
increase in oxidative stress. So the noted antioxidant effects of EEIS may also be 
ascribed secondary to decrease in calcium ions. Pregabalin treatment also increases 
GSH level, decreases TBARS and total calcium level. Oxidative stress may impair 
axonal membrane which was attenuated by EEIS treatment. EEIS showed significant 
antioxidant activity in invitro assays like DPPH and H2O2 . Neuroprotective effect of 
EEIS against acrylamide induced neuropathy may be due to the antioxidant potential 
of this extract, which has been proved by   both invivo and invitro antioxidant assays. 
Antioxidant property of EEIS may be due to the presence of tannins and flavonoids.       
      
Quercetin has already been reported for its neuroprotective effect against 
alcohol induced neuropathy by attenuating thermal hyperalgesia and also through 
modulation of membrane bound inorganic phosphate enzyme and inhibition of release 
of oxides,Inflammation mediators such as MDA (Melodialdehyde), MPO 
(Myeloperoxidase), and nitricoxide
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Quercetin has proven to protect against the development of diabetic 
neuropathy by inhibition of lipid peroxidation and restoration of antioxidant enzyme 
in diabetic rats, Thus reverse the oxidative stress induced changes in nerve physiology 
of diabetic rats are reported earlier. 
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                 Phytochemical studies revealed that  Compound mixture-II consist of two 
compounds and one of the identified  constituent   may be  quercetin, Administration 
of compound mixture –II to the acrylamide intoxicated rats  resulted attenuation of 
behavioural parameters such as paw and tail heat hyperalgesia (P< 0.05  )and cold 
allodynia ( P<0.05 )and biochemical parameters such as TBARS(P<0.05) total 
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calcium(P<0.05 ) and reduced GSH(P<0.05 ) as well as histopathological changes. 
Neuroprotective effect of compound mixture-II may be due to the presence of 
quercetin in this mixture. Isolated compound mixture and EEIS possess therapeutic 
potential on acrylamide induced biochemical and histopathological changes in 
rats.These ameliorative effect may be attributed due to the anti oxidative and 
neuroprotective potential of EEIS and isolated compound mixture-II and quercetin 
may be responsible for these activities. 
 
IN VITRO ANTI CANCER ACTIVITY 
Ethanolic extract of Ipomoea sepiaria was effective against invitro liver 
cancer cell lines of HepG2 cells at 500µg and the percentage cell inhibition was found 
to be 90.37% Quercetin has been reported for anti cancer activity. Hence the anti 
cancer activity of EEIS may be due to the presence of quercetin.
104
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CHAPTER-VIII 
CONCLUSION 
Many unknown plants, lesser known plants are used in folk and tribal medicine practices 
as a source of medicine. The medicinal values of these plants are not brought into the light of 
scientific world. One such plant is Ipomoea sepiaria.keeping in this view an attempt  was made 
to bring light to  the commonly available plant Ipomoea sepiaria. 
 
 This dissertation work entitled Pharmacognostical, phytochemical and the 
Pharmacological studies which have been dealt in this study. 
 
           Preliminary phytochemical screening of the Leaf and stem of this plant confirms that the 
presence of sterols, terpenoids, carbohydrates, proteins, flavonoids, tannins and saponins. 
 
           Estimation of total phenolics and flavonoids were determined for the ethanolic extract of 
this plant. 
 
          Phytoconstituents like flavonoids were isolated by column chromatography, Mixture-
I,mixture-II and a single compound were isolated, which gave positive reaction for 
flavonoids.Co- TLC Studies With quercetin revealed that one among the compound of mixture-II 
may be quercetin, Mixture-I and mixture-II were purified by preparative thinlayer 
chromatography(PTLC).Five compounds were isolated and compound IV was identified and this 
may be quercetin, which was evidenced by CO-TLC with standard quercetin. TLC,chemical test 
and IR spectral studies revealed that all the isolated compounds were flavanoids and compound 
IV may be quercetin. 
 
Antioxidant potential of isolated  compounds such as mixture-I,mixture-II and single 
compound were determined by DPPH method,mixture-II has significant radical scavenging 
property than mixture-I and single compound.Hence it was evaluated for invivo acrylamide 
induced painful neuropathy in rats. 
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PHARMACOLOGICAL SCREENING CONFIRMS, 
               Poly phenol secondary metabolites exhibited potent antioxidant activity. Quantitative 
estimation of EEIS showed significant total phenolic and flavanoid content. 
 
                EEIS exhibited potent antioxidant activity by invitro assays like DPPH and H2O2 
scavenging activity.It was further corroborated by the elevation of non enzymic endogenous 
antioxidant GSH and decreased in TBARS which is a marker compound for LPO (lipid 
peroxides) and reduced calcium ion levels in the nerve tissue homogenate of the EEIS treated 
acrylamide intoxicated animals. 
 
          It was concluded that EEIS showed significant antioxidant activity in both invitro and 
invivo antioxidant models. 
 
        EEIS treatment at 100mg/kg, 200mg/kg significantly normalizes the acrylamide intoxicated 
behavioural, biochemical, and histopathological changes and these effects may be due to the 
presence of antioxidant phytoconstituents like flavonoids. 
 
        The isolated  mixture compound-II was given at 5 mg/kg to the animals which showed  
significant  neuroprotective effect  for acrylamide induced painful neuropathy and this may be 
due to the antioxidant potential of quercetin and other flavonoid compounds.
101-103 
 
EEIS at 500µg showed significant invitro anticancer activity against HepG2 liver tumour 
cell lines. Quercetin like flavonoids have been reported for anti cancer activity
104
.Hence it is 
suggested that the active principle responsible for  treating  painful neuropathy and liver cancer 
may be isolated from Ipomoea sepiaria and evaluated for further studies. 
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